Processes related to preparation of fungicidal ARYL amidines
Efficient telescopic synthesis methods using Vilsmeier reagents and Lewis acids produce high-purity fungicidal aryl amidines, addressing the need for effective fungal pathogen control compounds.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- CORTEVA AGRISCIENCE LLC
- Filing Date
- 2025-11-04
- Publication Date
- 2026-05-15
AI Technical Summary
There is a need for efficient and scalable processes to synthesize fungicidal aryl amidines, particularly compounds like 4-(difluoromethoxy)benzyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate and their derivatives, which are effective against fungal pathogens.
The synthesis involves telescopic reactions using Vilsmeier reagents, Lewis acids, acyl chlorides, and various solvents to convert intermediates into desired compounds, with optional use of catalysts and phase-transfer agents to optimize yields and purities.
The processes enable the production of high-purity fungicidal aryl amidines, including 4-(difluoromethoxy)benzyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate, suitable for agricultural applications.
Smart Images

Figure IMGF000002_0001 
Figure IMGF000003_0001 
Figure IMGF000003_0002
Abstract
Description
PROCESSES RELATED TO PREPARATION OF FUNGICIDAL ARYL AMIDINESCROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 718,610 filed November 9, 2024, which is expressly incorporated by reference herein.BACKGROUND
[0002] The fungicidal aryl amidine compound, 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI), an acceptable salt, solvate, or hydrate thereof, has been disclosed in application PCT / US2024 / 027678.SUMMARY
[0003] A compound, A’-(2,5-dimethylphenyl)- / V-ethyl-A-methylformimidamide (S2), having the following formula, is provided.
[0004] A compound, A’-(2,5-dimethylphenyl)-A-ethyl-A-methylformimidamide hydrochloride (S2-HC1), having the following formula is provided.CH3CH3A / N ^N ^CH3|l J HCICH3S2-HCI
[0005] A compound (S3), wherein Ri is Cs-Cs alkyl, having the following formulaan acceptable salt thereof is provided.
[0006] A compound, isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5- dimethylbenzoate (S3a), having the following formula is provided.S3a
[0007] A compound, isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5- dimethylbenzoate hydrochloride (S3a-HCl), having the following formula is provided.S3a-HCI
[0008] Processes to make and use a compound of S2 or S2-HC1 are provided.
[0009] Processes to make and use a compound of S3 are provided. Processes to make and use compounds of S3a and S3a-HCl are provided.
[0010] Additionally, processes related to the preparation of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable salt, solvate, or hydrate thereof are provided. The compounds S2, S3, and S5 and acceptable salts thereof may be useful in the process to prepare 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable salt, solvate, or hydrate thereof.DETAILED DESCRIPTION
[0011] A compound, A’-(2,5-dimethylphenyl)-A-ethyl-A-methylformimidamide (S2), having the following formula,an acceptable salt thereof is provided.
[0012] A compound, A’-(2,5-dimethylphenyl)-? / -ethyl-A-methylformimidamide hydrochloride (S2-HC1), having the following formula is provided.S2-HCI
[0013] A compound (S3), wherein Ri is C3-C8 alkyl, having the following formulaCH3CH3X .N^N^CH3■ AV o CH3an acceptable salt thereof is provided.
[0014] A compound, isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5- dimethylbenzoate (S3a), having the following formula is provided.S3a
[0015] A compound, isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5- di methylbenzoate hydrochloride (S3a-HCl), having the following formula is provided.S3a-HCI
[0016] Processes to make and use a compound of S2 are provided. Processes to make and use a compound of S2-HC1 are provided.
[0017] Processes to make and use a compound of S3 are provided. Processes to make and use compounds of S3a and S3a-HCl are provided.
[0018] Further, processes related to the formation of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable salt, solvate, or hydrate thereof are provided. The compounds S2, S3, and S5 and acceptable salts thereof may be useful in the process to prepare 4-(difluoromethoxy)benzyl 4-(((ethyl (methyl )amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable salt, solvate, or hydrate thereof.
[0019] The following are processes related to the formation of 4-(difluoromethoxy)benzyl 4- (((ethyl (methyl )amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable salt, solvate, or hydrate thereof.
[0020] Definitions
[0021] It is understood that a substituent should comply with chemical bonding rules and steric compatibility constraints in relation to the particular compound to which it is attached. These definitions are only to be used for the purposes of this disclosure.
[0022] Throughout the disclosure, reference to the compound of SI or compounds of SI is read as also including acceptable salts, solvates, or hydrates thereof, unless otherwise indicated herein or clearly contradicted by context.
[0023] Throughout the disclosure, reference to the compound of or compounds of SI, S2, S3, and S5 and acceptable salts thereof is read as also including all regioisomers, structural isomers, geometrical isomers, rotational isomers, tautomers, and stereoisomers, for example diastereomers, enantiomers, and mixtures thereof.
[0024] The compounds of the disclosure may also contain linkages (e.g., carbon-carbon bonds) wherein bond rotation is restricted about that particular linkage e.g., restriction resulting from the presence of a ring or a double bond. Accordingly, any cis / trans and E / Z isomers are expressly included in the present disclosure.
[0025] The compounds of the disclosure may also be present in multiple tautomeric forms. Where one or more tautomeric forms exist, the disclosure expressly includes all such tautomeric forms of the compounds described herein, even though only a single tautomeric form may be represented.
[0026] The term “ambient pressure” refers to pressures from about 80 kilopascals (kPa) to about 105 kPa.
[0027] The term “ambient temperature” or “room temperature” refers to temperatures ranging from about 20 °C to about 24 °C.
[0028] The term “catalyst” refers to any substance that increases the rate of a reaction without itself being consumed.
[0029] The term “telescope process” or “telescopic reaction” means a type of synthesis that subjects a reactant or reactants to successive chemical reactions in a sequential order in just one reactor or without isolation of intermediates.
[0030] An acid equivalent is dependent upon the number of protons an acid can deliver. For example, hydrochloric acid has one molar equivalent of acid, while oxalic acid has two.
[0031] Scheme OneS4 S2 or salt thereof
[0032] The reaction of Scheme One is done in the presence of a Vilsmeier reagent, also known herein as reagent V, which is prepared by reacting a formamide, R2R3NCHO, wherein R2 and R3 are independently C1-C2 alkyl and may or may not be the same, with an activating compound. Examples of formamides include N, A-dimethylformamide, A,A-diethylformamide, and A-ethyl-A-methyl formamide. Examples of activating chlorides include oxalyl dichloride, phosgene, diphosgene, triphosgene, phosphoryl chloride, phosphorus trichloride, phosphorus pentachloride, and thionyl chloride. In general, from about 0.9 moles to about 3 moles of reagent V per mole of S4 may be used; preferably, from about 1.0 moles to about 2.5 moles of reagent V per mole of S4 may be used.
[0033] The reaction of Scheme One is conducted in the presence of a polar or a nonpolar solvent. Examples of solvents are ethyl acetate (“EtOAc”), tetrahydrofuran (“THF”), di chloromethane ("DCM”), and toluene (“PhCFh”). Optionally, mixtures of solvents may be used.
[0034] The reaction of Scheme One may be conducted at temperatures from about -20 °C to about 100 °C, preferably from about 10 °C to about 50 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0035] The product of Scheme One may be isolated as an acceptable salt or neutral form depending upon the addition of an appropriate acid or base used. Examples include the addition of sodium or potassium bases to S2-HC1 to afford the neutral form of S2 or the addition of hydrochloric acid to S2 to provide S2-HC1.
[0036] The reaction of Scheme One may be conducted in batch or in continuous process.
[0037] Scheme TwoS2 or salt thereof S3 or salt thereof R-i = C-|-C8alkylS1 or salt thereof
[0038] The reaction of Steps Al, A2, and A3 in Scheme Two is conducted in the presence of a Lewis acid, an acyl chloride, and a solvent, whereby S2 or salt thereof is transformed.Examples of Lewis acids are boron trifluoride (“BF3”), aluminum trichloride (“AlCh”), and iron trichloride (“FeCh”). In general, from about 1 mole to about 5 moles of Lewis acid per mole of S2 or salt thereof may be used; preferably, from about 1.5 moles to about 3.5 moles of Lewis acid per mole of S2 or salt thereof may be used.
[0039] The reaction of Steps Al, A2, and A3 in Scheme Two is conducted in the presence of an acyl chloride. Examples of acyl chlorides are oxalyl dichloride, phosgene, diphosgene, triphosgene, methyl chloroformate, and ethyl chloroformate. In general, from about 1 mole to about 5 moles of acyl chloride equivalent per mole of S2 or salt thereof may be used; preferably, from about 1.5 moles to about 3.5 moles of acyl chloride equivalent per mole of S2 or salt thereof may be used.
[0040] The reaction of Steps Al, A2, and A3 in Scheme Two is conducted in the presence of a solvent. Examples of solvents are chlorobenzene (“PhCl”), dichlorobenzene, chloroform (“CHCh”), di chloromethane ("DCM”), 1,2-di chloroethane (“DCE”), tri chlorotoluene, and toluene (“PhCEE”). Optionally, mixtures of solvents may be used.
[0041] The reaction of Steps Al, A2, and A3 in Scheme Two may be conducted at temperatures from about -20 °C to about 20 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0042] The products of the reaction of Steps Al, A2, and A3 in Scheme Two may be 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid (also known as S5 herein) or salt thereof (Step Al), an ester (S3), wherein Ri is Ci-Cs alkyl, or salt thereof (Step A2), or SI or salt thereof (Step A3), depending upon how the reaction is terminated. The reaction of Steps Al, A2, and A3 in Scheme Two may be terminated by the addition of hydrolytic agents including water and aqueous acids, such as aqueous hydrochloric acid (Step Al), Ci-Cs alkyl alcohols (Step A2), such as methanol, ethanol, propan- l-ol, propan-2-ol, butan-l-ol, butan-2-ol, 2- methylpropan-l-ol, pentan-l-ol, 3-methylbutan-l-ol, 2-ethylhexan-l-ol, or 4- (difluoromethoxy)phenyl)methanol (Step A3).
[0043] The products of Steps Al, A2, and A3 in Scheme Two may be isolated as an acceptable salt or neutral form depending upon the addition of an appropriate acid or base. Examples include the addition of sodium or potassium bases, such as sodium or potassium hydroxide, sodium or potassium phosphate dibasic, sodium or potassium phosphate tribasic, sodium or potassium carbonate, or sodium or potassium bicarbonate to S5 or acceptable salt thereof (e.g., S5-HC1) to afford the corresponding carboxylate (S5-Na and S5-K); the addition ofsodium or potassium bases, such as sodium or potassium hydroxide, sodium or potassium phosphate dibasic, sodium or potassium phosphate tribasic, sodium or potassium carbonate, or sodium or potassium bicarbonate to S3-HC1 to afford the neutral forms of S3; and the addition of sodium or potassium bases such as sodium or potassium hydroxide, sodium or potassium phosphate dibasic, sodium or potassium phosphate tribasic, sodium or potassium carbonate, or sodium or potassium bicarbonate to S1-HC1 to afford the neutral forms of SI.
[0044] As in Step B of Scheme Two, the ester, S3, or acceptable salt thereof (e.g., S3-HC1) may be converted to S5 or the corresponding carboxylate (S5-Na and S5-K)thereof, by treatment with a base, such as sodium hydroxide, in the presence of a solvent, such as an alcohol, tetrahydrofuran (“THF”), acetonitrile (“ACN”), N, A-dimethylformamide (“DMF”), or toluene. In general, from about 1.0 moles to about 3 moles of base per mole of S3 may be used; preferably, from about 1.1 moles to about 2 moles of base per mole of S3 may be used. One skilled in the art would recognize that more equivalents of base may be necessary if a salt form of S3 is used. Mixtures of bases may also be used. Optionally, the process may be terminated by the addition of hydrochloric acid to provide S5-HC1.
[0045] Alternatively, as in Step B of Scheme Two, the ester, S3, or acceptable salt thereof may be converted to S5 or acceptable salt thereof, by treatment with an acid, such as hydrogen chloride delivered as a solution in organic solvent, water, or as a gas, in the presence of solvent, such as an alcohol, tetrahydrofuran (“THF”), toluene, or water. In general, from about 1 mole to about 25 moles of acid per mole of S3 may be used; preferably, from about 1.1 moles to about 20 moles of acid per mole of S3 may be used. In another aspect, aqueous solutions of various salts, including but not limited to sodium chloride, may be added to improve recovery of the S5 salts, such as S5-HC1.
[0046] The reaction of Step B in Scheme Two may be conducted at temperatures from about ambient to about 100 °C, or from about 70 °C to about 100 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0047] Any neutral form of ester S3 may be converted to the hydrochloride or other acceptable salt thereof. In general, from about 1.0 moles to about 3 moles of hydrogen chlorideor other acid per mole of S3 may be used; preferably, from about 1.2 moles to about 2.5 moles of hydrogen chloride per mole of S3 may be used. The neutral form of SI may be converted to the hydrochloride or other acceptable salt thereof. In general, from about 1.0 moles to about 3 moles of hydrogen chloride or other acid per mole of SI may be used; preferably, from about 1.2 moles to about 2.5 moles of hydrogen chloride per mole of SI may be used. This transformation may be conducted at temperatures from about -10 °C to about 35 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0048] Scheme Three
[0049] The reaction sequence of Scheme Three provides the preparation of l-(chloromethyl)- 4-(difluoromethoxy)benzene (S9).
[0050] The reaction of Step A in Scheme Three, whereby 4-hydroxybenzaldehyde (S6) is transformed into 4-(difluoromethoxy)benzaldehyde (S7, not shown), may be conducted in the presence of a base, an alkylating agent, and solvent. Examples of bases are sodium hydroxide (“NaOH”), potassium hydroxide (“KOH”), potassium carbonate (“K2CO3”), potassium phosphate (“K3PO4”), and sodium carbonate (“Na^CCh”). In general, from about 1.5 moles to about 10 moles of base per mole of S6 may be used; preferably, from about 2 moles to about 5 moles of base per mole of S6 may be used. Mixtures of bases may also be used.
[0051] The reaction of Step A in Scheme Three is conducted in the presence of an alkylating agent. Examples of alkylating agents include but are not limited to derivatives of ethyl bromodifluoroaceate, sodium chlorodi fluoroacetate, fluoroform, diethyl (bromodifluoromethyl)phosphonate and chlorodifluoromethane (also known as Freon-22). In general, from about 1 mole to about 5 moles of alkylating agent per mole of S6 may be used; preferably, from about 1.2 moles to about 3 moles of base per mole of S6 may be used.
[0052] The reaction of Step A in Scheme Three is conducted in the presence of a solvent. Examples of solvents are toluene (“PhCFb”), N, A-dimethylformamide (“DMF”), water, ethanol(“EtOH”), isopropanol (“z-PrOH”), / -butanol (“ / -BuOH”), / -amyl alcohol (“TAA”), tetrahydrofuran (“THF”), dichloromethane ("DCM”), and acetonitrile (“ACN”). Optionally, mixtures of solvents may be used and are preferred.
[0053] The reaction of Step A in Scheme Three may be conducted at temperatures from about -5 °C to about 65 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0054] The reaction of Step B in Scheme Three is conducted in the presence of a reducing agent and a solvent and affords 4-(difluoromethoxy)phenyl)methanol (S8, not shown). Examples of reducing agents are sodium borohydride, lithium borohydride, and hydrogen gas in the presence of a transition metal catalyst such as nickel, palladium, platinum or rhodium. In general, from about 1 mole to about 5 moles of reducing agent equivalent per mole of 4- (difluoromethoxy)benzaldehyde (S7) may be used; preferably, from about 1.1 moles to about 4 moles of reducing agent equivalent per mole of S7 may be used. Alternatively, the aldehyde may be reduced via reaction with a surrogate aldehyde, such as formaldehyde.
[0055] The reaction of Step B in Scheme Three is conducted in the presence of a solvent. Examples of solvents are acetonitrile (“ACN”), isopropanol (“z-PrOH”), / -butanol (“ / -BuOH”), / - amyl alcohol (“TAA”), methanol (“MeOH”), ethanol (“EtOH”), aqueous sodium hydroxide, and tetrahydrofuran (“THF”). Optionally, mixtures of solvents may be used.
[0056] The reaction of Step B in Scheme Three may be conducted at temperatures from about -5 °C to about 35 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0057] Alternatively, Steps A and B may be done in reverse order.
[0058] The reaction of Step C in Scheme Three is conducted in the presence of a chlorinating agent and a solvent and affords l-(chloromethyl)-4-(difluoromethoxy)benzene (S9). Examples of chlorinating agents are phosgene, diphosgene, triphosgene, hydrogen chloride, thionyl chloride, phosphorus oxychloride, oxalyl dichloride, phosphorus trichloride, and phosphorus pentachloride. In general, from about 1 mole to about 3 moles of chlorinating agent per mole of(4-(difluoromethoxy)phenyl)methanol (S8) may be used; preferably, from about 1.0 moles to about 2 moles of chlorinating agent per mole of S8 may be used.
[0059] The reaction of Step C in Scheme Three is conducted in the presence of a solvent. Examples of solvents are toluene (“PhCHa”), di chloromethane ("DCM”), 1,2-di chloroethane ("DCE”), chloroform (“CHCh”), and chlorobenzene (“PhCl”). Optionally, mixtures of solvents may be used.
[0060] The reaction of Step C in Scheme Three may be conducted at temperatures from about -5 °C to about 35 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0061] In one aspect, purification of one or more of S7, S8 or S9 may be accomplished by melt crystallization. See, for example, melt crystallization processes described \n Melt Crystallization: Fundamentals, Equipment and Applications, Ulrich, J., Glade, H., Eds.; Shaker: Aachen, 2003.S1 or salt thereof
[0063] The reaction of Scheme Four A is conducted in the presence of a base, a solvent, and optionally a phase-transfer catalyst. Examples of bases are organic bases and inorganic bases. Examples of bases are sodium methoxide (“NaOCHs”), sodium ethoxide (“NaOCTECHs”), N,N- di isopropyl ethyl amine (“DIPEA”), triethylamine (“EtsN”), potassium carbonate (“K2CO3”), cesium carbonate (“CS2CO3”), sodium carbonate (“Na2CO3”), sodium hydroxide (“NaOH”), andsodium bicarbonate (“NaHCOs”) or mixtures thereof. The preferred base includes potassium carbonate. In general, from about 1.0 mole to about 5 moles of base per mole of S5 may be used; preferably, from about 1.5 moles to about 3 moles of base per mole of S5 may be used. One skilled in the art would recognize that more equivalents of base may be necessary if a salt form of S5 is used.
[0064] The reaction of Scheme Four A is conducted in the presence of a polar solvent. Examples of polar solvents are water, ethyl acetate (“EtOAc”), acetone, acetonitrile (“ACN”), methyl ethyl ketone (“MEK”), A-dimethylformamide (“DMF”), dimethyl sulfoxide (“DMSO”), isobutyl acetate (“z-BuOAc”), and tetrahydrofuran (“THF”). Optionally, mixtures of solvents may be used. The preferred solvent includes ethyl acetate.
[0065] The reaction of Scheme Four A is conducted in the presence of an optional phasetransfer catalyst. Examples of phase-transfer catalysts are tetramethylammonium bromide (“TMAB”), tetraethylammonium bromide (“TEAB”), tetrapropylammonium bromide (“TP AB”), tetrabutylammonium bromide (“TBAB”), and benzyl triethylammonium chloride (“BTEAC”). Preferred phase-transfer catalysts include tetramethylammonium bromide (“TMAB”), tetraethylammonium bromide(“TEAB”), tetrapropylammonium bromide (“TP AB”), tetrabutylammonium bromide (“TBAB”), and benzyl triethylammonium chloride (“BTEAC”). The most preferred phase-transfer catalyst includes benzyl triethylammonium chloride (“BTEAC”). In general, from about 0.01 moles to about 0.5 moles of phase-transfer catalyst per mole of S5 may be used; preferably, from about 0.05 moles to about 0.15 moles of phase-transfer catalyst per mole of S5 may be used.
[0066] The reaction of Scheme Four A may be conducted at temperatures from about 30 °C to about 70 °C, and ambient pressures from about 95 kilopascals (kPa) to about 105 kPa (usually about 101 kPa). However, higher and lower temperatures and pressures may be used.
[0067] Scheme Four BS1 or salt thereof
[0068] The reaction of Scheme Four B shows a process for the preparation of SI or an acceptable salt thereof via an activated carboxylic acid S5-A or an acceptable salt thereof. An activated carboxylic acids S5-A or an acceptable salt thereof, wherein A is an activating group, may be an acid halide, a mixed anhydride, or an acyl carbonate. Treatment of the activated carboxylic acid S5-A or an acceptable salt thereof with S8 affords SI or acceptable salt thereof.
[0069] In one preferred aspect, the activated carboxylic acid is an acid halide. The conversion of a carboxylic acid S5 or an acceptable salt thereof to an activated carboxylic acid S5-A or acceptable salt thereof shown in Scheme Four B is conducted in the presence of a carboxylic acid activator, an optional base, and a solvent. For an acid halide S5-A or acceptable salt thereof wherein A is Cl, examples of a carboxylic acid activator are thionyl chloride, phosphorus pentachloride, and oxalyl dichloride. A preferred carboxylic acid activator is thionyl chloride. Examples of an optional base are triethylamine (“EtsN”), A(A-di isopropyl ethyl amine (“DIPEA”), pyridine, sodium carbonate (“Na2CO3”), potassium carbonate (“K2CO3”), and sodium bicarbonate (“NaHCCh”). Preferred optional bases are sodium carbonate and potassium carbonate. In one preferred aspect, no base is used. Examples of solvents are toluene (“PI1CH3”), ethyl acetate (“EtOAc”), dichloromethane (“DCM”), and tetrahydrofuran (“THF”). Preferred solvents are tetrahydrofuran and dichloromethane.
[0070] Scheme Four CS3 or salt thereof
[0071] The reaction of Scheme Four C shows a process for the preparation of S3 or an acceptable salt thereof via an activated carboxylic acid S5-A or acceptable salt thereof. Activated carboxylic acids S5-A or salt thereof, wherein A is an activating group, may be an acid halide, a mixed anhydride, or an acyl carbonate. Treatment of the activated carboxylic acid S5-A or salt thereof with an alcohol such as RiOH, wherein Ri is Ci-Cs alkyl, affords S3 or acceptable salt thereof.
[0072] In one preferred aspect, the activated carboxylic acid is an acid halide. The conversion of a carboxylic acid S5 or an acceptable salt thereof to an activated carboxylic acid S5-A or an acceptable salt thereof is conducted in the presence of a carboxylic acid activator, an optional base, and a solvent. For an acid halide S5-A or an acceptable salt thereof wherein A is Cl, examples of a carboxylic acid activator are thionyl chloride, phosphorus pentachloride, and oxalyl dichloride. A preferred carboxylic acid activator is thionyl chloride. Examples of an optional base are triethylamine (“EtsN”), ACV-diisopropylethylamine (“DIPEA”), pyridine, sodium carbonate (“Na2CO3”), potassium carbonate (“K2CO3”), and sodium bicarbonate (“NaHCCh”). Preferred optional bases are sodium carbonate and potassium carbonate. In one preferred aspect, no base is used. Examples of solvents are toluene (“PhCEE”), ethyl acetate(“EtOAc”), di chloromethane (“DCM”), and tetrahydrofuran (“THF”). Preferred solvents are tetrahydrofuran and dichloromethane.S1 or salt thereof
[0074] The reaction of Scheme Five is conducted in the presence of a catalyst and a solvent. Examples of Lewis acid catalysts are dibutyltin oxide, dibutyltin laurate, dibutyltin acetate, titanium isopropoxide, aluminum isopropoxide, and zirconium isopropoxide. Examples of base catalysts are sodium methoxide (“NaOCFh”), potassium methoxide (“KOCH3”), sodium ethoxide (“NaOCFECHa”), sodium pentoxide (“NaOCFECFECFECFECFb”), potassium tert- butoxide (“KOt-Bu”), potassium Zc / 7-amylate (“K0- / -Am”), sodium / c77-butoxide (“NaOt-Bu”), sodium hydroxide (“NaOH”), potassium hydroxide (“KOH”), and sodium hydride (“NaH”). Mixtures of catalysts may also be used. Preferred catalysts include dibutyltin oxide, dibutyltin laurate, dibutyltin acetate, and sodium hydride. In general, for base catalysts, if the ester hydrochloride salt is used, from about 1 mole to about 3 moles of catalyst per mole of S3-HC1 may be used; preferably, from about 1.0 mole to about 2.5 moles of catalyst per mole of S3-HC1 may be used. In general, if the S3 neutral form is used, from about 0.01 mole to about 0.3 mole of catalyst per mole of S3 may be used; preferably, from about 0.05 moles to about 0.2 moles of catalyst per mole of S3 may be used. In general, for Lewis acid catalysts, from about 0.05 mole to about 0.5 mole of catalyst per mole of S3 or S3-HC1 may be used; preferably, from about 0.1 mole to about 0.3 mole of catalyst per mole of S3 or S3-HC1 may be used.
[0075] The reaction of Scheme Five is conducted in the presence of a solvent. Examples of solvents are 1,4-dioxane, tetrahydrofuran (“THF”), 2-methyltetrahydrofuran (“2-MeTHF”), dibutyl ether, acetonitrile (“ACN”), cyclopentyl methyl ether (“CPME”), anisole, diphenyl ether, cyclohexane, xylenes, mesitylene, 1,2-di chlorethane (“DCE”), trifluorotoluene, toluene, chlorobenzene, dichlorobenzene, benzonitrile. Optionally, mixtures of solvents may be used. The preferred solvent includes xylenes.
[0076] The reaction of Scheme Five may be conducted at temperatures from about 25 °C to about 120 °C, preferably from about 40 °C to about 100 °C, and more preferably from about 50 °C to 90 °C, and from about 1 kilopascal (kPa) to about 200 kPa or from 1 kPa to about 101 kPa. However, higher and lower temperatures and pressures may be used.
[0077] A solution containing SI may be converted to the hydrochloride salt by the addition of hydrogen chloride as a solution in organic solvent or water or as a gas.
[0078] A solution containing S1-HC1 or other acceptable salt may be converted to the neutral form of SI by addition of a solution of sodium hydroxide or other acceptable base.
[0079] A solution containing the neutral form of SI may be crystallized into a solid form of SI by the use of an appropriate solvent and anti-solvent, by employing a seed material as needed, and by modifying the temperature of the mixture. Examples of solvents include dichloromethane (“DCM”), isobutyl acetate, isopropyl acetate, isopropanol, ethyl acetate, methyl / e / 7-butyl ether (“MTBE”), toluene, and dibutyl ether. Examples of anti-solvents include cyclohexane, n- heptane, Isopar-C®, petroleum ether, and water. Examples of solvent-anti-solvent mixtures include ethereal solvent-hydrocarbon solvent mixtures. Examples of such mixtures are dibutyl ether- / -heptane and methyl / c? / 7-butyl ether (“MTBE”)- / / -heptane. Examples of seed material may be the particles of previously crystallized SI, further processed as needed. The crystallization may be conducted at temperatures from about 60 °C to about -20 °C. One skilled in the art would recognize that this crystallization method may provide increased yield and / or purity or may avoid oiling of the product.
[0080] A solution containing the acceptable salt form of SI (e.g., S1-HC1) may be crystallized into a solid form of S1-HC1 by the use of an appropriate solvent, containing an appropriate moisture content, and optionally, an anti-solvent, by employing a seed material asneeded, and by modifying the temperature of the mixture. Examples of solvents include isobutyl acetate, isopropyl acetate, isopropanol, and ethyl acetate. Examples of anti-solvents include cyclohexane, heptane, Isopar-C®, and petroleum ether. Examples of seed material may be the particles of previously crystallized S1-HC1, further processed as needed. The crystallization may be conducted at temperatures from about 60 °C to about -20 °C.
[0081] The following examples further illustrate the invention but, of course, should not be construed as in any way limiting its scope.
[0082] rH NMR spectral data are in ppm (5) and were recorded at 400 and 500 MHz;13C NMR spectral data are in ppm (8) and were recorded at 101 and 126 MHz; and19F NMR spectral data are in ppm (8) and were recorded at 376 and 471 MHz, unless otherwise stated.
[0083] In the examples, the following abbreviations have the following meanings. If an abbreviation is not defined, it has its generally accepted meaning. equiv = equivalent mg = milligrams g = gram kg = kilogram wt % = weight percent h = hours min = minutes sec = secondsRT = room temperature rpm = revolutions per minuteHC1 = hydrochloric acidHPLC = high-performance liquid chromatographyUPLC = ultra-performance liquid chromatography kPa = kilopascalsLCMS = liquid chromatography mass spectrometryM = molarN = normalmmol = millimoles pM = micromolar mL = milliliterL = liters vol = volumes (mL / g)EtOAc = ethyl acetateDCM = dichloromethaneTHF = tetrahydrofuranMeOH = methanolEtOH = ethanol / -PrOH= isopropanolMTBE = methyl tert-butyl ether aq = aqueousEXAMPLE 1
[0084] Synthesis of N-methylethanamine (S12)Step AH3Ph. ^O - - Hhf ,CH32. Step BJS10 S12
[0085] Preparation 1, Step A: Synthesis ofN-methyl-l-phenylmethanimine (Sila)
[0086] A round-bottom flask with a stir bar was charged with benzaldehyde (S10, 53.1 g, 500 mmol). The flask was placed in an ice bath and cooled to 5-10 °C. Methylamine (aqueous, 40 wt %, 38.8 g, 525 mmol) was added slowly through an addition funnel, and the temperature of the reaction mixture was maintained below 20 °C. The reaction mixture was warmed to ambient temperature and was stirred for another 3 h. The reaction mixture was partitioned, and the organic layer was collected. Toluene (50 mL) was added to the organic layer, and the mixture was concentrated under vacuum to azeotrope water. Once the mixture was concentrated, this procedure was repeated. Additional toluene (20 mL) was added, and the mixture was concentrated under vacuum. A-Methyl-l-phenylmethanimine (Sila) was isolated as a colorlessoil (59.6 g, 85% yield): 'H NMR (500 MHz, CDCh) 5 8.28 (t, J= 1.7 Hz, 1H), 7.70 (dd, J= 6.7, 3.0 Hz, 2H), 7.40 (p, J= 3.4 Hz, 3H), 3.51 (d, J= 1.7 Hz, 3H);13C N R (126 MHz, CDCh) 5 162.48, 136.25, 130.51, 128.60, 127.87, 48.23; MS (El) calcd for CsH9N+[M]+119.1; found 118.1.
[0087] Preparation 1, Step B: Synthesis of N-methylethanamine (S12)
[0088] A round-bottom flask with a stir bar was charged with A-methyl-1- phenylmethanimine (Sila, 85 wt %, 14.0 g, 100 mmol). Diethyl sulfate (15.4 g, 100 mmol) was added via syringe over 2 min. The reaction mixture was heated to 60 °C and was stirred for 5 h. The mixture was cooled to ambient temperature, water (10 g) was added, and the reaction mixture was stirred for 30 min. The reaction mixture was partitioned, and the aqueous layer was extracted with toluene (2 x 5 m ). The resulting aqueous mixture was transferred to a roundbottom flask, and the mixture was cooled to 5-10 °C in an ice bath. To this mixture was added sodium hydroxide solution (aqueous, 50 wt %, 20 g) slowly over 5 min, and the internal temperature was maintained below 20 °C. Short-path distillation and condensation with ice water provided A-methylethanamine (S12) as a colorless oil (3.91 g, 66% yield): 'H NMR (500 MHz, CDCh) 6 2.62 (qd, J= 7.1, 0.7 Hz, 2H), 2.44 (d, J= 0.7 Hz, 3H), 1.10 (td, J= 7.2, 0.7 Hz, 3H);13C NMR (126 MHz, CDCh) 846.29, 36.37, 15.17; bp 30-33 °C; MS (El) m'z calcd for C3H9N+[M]+59.1, found 59.1.
[0089] Preparation 2, Step A: Synthesis ofN-ethyl-l-phenylmethaninhne (SI lb)
[0090] A round-bottom flask with a stir bar was charged with benzaldehyde (S10, 53.1 g, 500 mmol). The flask was placed in an ice bath and cooled to 5-10 °C. Ethylamine (69 wt % aq, 34.3 g, 525 mmol) was added through an addition funnel over 20 min, and the temperature of the reaction mixture was maintained below 20 °C. After complete addition, the reaction mixture was warmed to ambient temperature and was stirred for another 3 h. The reaction mixture was partitioned, the aqueous layer was removed, and the organic layer was collected. Toluene (20 mb) was added to the organic layer, and the mixture was concentrated under vacuum. Once the mixture was concentrated, this was repeated. Additional toluene (20 mb) was added, and the mixture was concentrated under vacuum. After concentrating, A'-cthyl - I -phenyl methaniminc (Sllb) was isolated as a colorless oil (71.5 g, 96% yield): *HNMR (500 MHz, CDCh) 8 8.30 (t,J= 1.4 Hz, 1H), 7.76 - 7.69 (m, 2H), 7.45 - 7.36 (m, 3H), 3.65 (qd, J= 7.3, 1.4 Hz, 2H), 1.31 (t, J= 13 Hz, 3H);13C NMR (126 MHz, CDCh) 8 160.46, 136.35, 130.47, 128.58, 127.99, 55.89, 16.31; MS (El) cal cd for C9HnN+[M]+133.1; found 132.1.
[0091] Preparation 2, Step B: Synthesis of N-methylethanamine (S12)
[0092] A round-bottom flask with a stir bar was charged with A-ethyl-l-phenylmethanimine (Sllb, 89 wt %, 15.0 g, 100 mmol). Dimethyl sulfate (12.6 g, 100 mmol) was added via a syringe over 2 min. After complete addition, the reaction mixture was heated to 40 °C and was stirred for 3 h. The mixture was then cooled to ambient temperature, water (10 g) was added, and the reaction mixture was stirred for 30 min. The reaction mixture was partitioned, and the organic layer was removed. The aqueous layer was mixed with toluene (5 mL), and the resulting organic layer was removed. Additional toluene (5 mL) was added to extract the aqueous layer, and the organic layer was removed. The resulting mixture was transferred to a round-bottom flask placed in ice bath and cooled to 5-10 °C. To this mixture was added NaOH solution (50 wt % aq, 20 g) slowly over 5 min, and the internal temperature was maintained below 20 °C. After addition, the mixture was distilled via short-path distillation. / V-Methylethanamine (S12) was isolated as a colorless oil (4.73 g, 80% yield). Analytical data matched those above.EXAMPLE 2
[0093] Synthesis of N-ethyl-N-methyl formamide (S13)
[0094] Method 1, Preparation 1: A reactor, under inert atmosphere and equipped with an overhead agitator, nitrogen inlet, and temperature probe, was charged with potassium tert- butoxide (12.3 g, 110 mmol) and THF (50 mL). The mixture was stirred at 25 °C. N- Methylformamide (S14, 5.84 mL, 100 mmol) was added to the reaction mixture slowly over 15 min. After complete addition, the mixture was stirred at 25 °C for 15 min. The reaction mixture was heated to 50 °C. Bromoethane (S15, 11.9 mL, 160 mmol) was added slowly over 15 min, maintaining a temperature of 50 °C. After complete addition, the mixture was stirred for an additional 16 h at 50 °C. After >98% conversion was observed by GC, the reaction mixture wascooled to 25 °C. The reactor was drained, the mixture was filtered to remove solids, and the solids were washed with THF (50 mL). Subsequently, the filtrate was distilled under vacuum (approximately 10 kPa (100 mbar)) and distillation fractions were collected and analyzed. Fractions with product were combined to afford A-ethyl-A-methyl formamide (S13, 6.63 g, 76% yield) as a colorless oil: Observed as a mixture of rotamers:1H NMR (500 MHz, CDCI3) 5 8.07 (s, 0.6H), 8.00 (s, 0.4H), 3.39 (q, J= 7.2, 0.8H), 3.30 (q, J= 7.2 Hz, 1.2H), 2.93 (s, 1.2H), 2.86 (s, 1.8H), 1.20 (t, J= 7.2, 1.1 Hz, 1.9H), 1.13 (t, = 7.2, 1.2 Hz, 1.2H);13C NMR (126 MHz, CDCI3) (mixture of rotamers) 5 162.35, 162.20, 44.26, 38.79, 33.93, 28.92, 14.13, 11.91; MS (El) m / z calcd for C4H9NO+[M]+87.1, found 87.1.
[0095] Method 1, Preparation 2: In a 500 mL jacketed reactor with a positive nitrogen inlet, tetrabutylammonium bromide (TBABr, 1.29 g, 4.0 mmol) and THF (100 mL) were charged and stirred at 250 rpm. The internal temperature was adjusted to 30 °C before sodium ter / -butoxide (21.1 g, 220 mmol) was added in three portions over 1 min. A-Methylformamide (S14, 11.7 mL, 200 mmol) was added via a syringe over 5 min. The mixture was stirred at 30 °C for 15 min before bromoethane (S15, 17.9 mL, 240 mmol) was added using a syringe pump over 20 min. The resulting mixture was stirred overnight at 30 °C. The reaction mixture was drained and filtered into a round-bottom flask under vacuum. Additional THF (100 mL) was used to wash the reactor and the filter cake. The filtrate was sampled providing an assay yield of S13 product as 96%.
[0096] Method 2, Preparation 1: To a 1 L reactor, A-methylformamide (S14, 23.4 mL, 400 mmol) and toluene (400 mL) were added at ambient temperature. The reaction mixture was heated to 50 °C with stirring at 500 rpm. Sodium te / 7-butoxide (42.3 g, 440 mmol) was added. Diethyl sulfate (S16, 52.4 mL, 400 mmol) was then added over the course of 1 h. The reaction temperature was maintained at 50 °C and stirred overnight. The reaction mixture was filtered under vacuum. The filter cake was washed twice with toluene (2 x 100 mL), and an aliquot from the combined filtrate was analyzed by GC with an assay yield of 85%. Subsequently, the post-filtration mixture was transferred to a round-bottom flask for distillation. Fractions containing product were combined to afford A-ethyl-A-methylformamide (S13, 22.5 g, 65% yield) as a colorless oil. Analytical data matched those above.
[0097] Method 2, Preparation 2: A 50 mL three-neck round-bottom flask with a condenser and under nitrogen was charged with / -butanol ( / -BuOH, 10 mL). Sodium metal (138 mg, 6.0 mmol) was added to the flask. The reaction mixture was heated to 80 °C and stirred for 5 h, and the reaction mixture became a white slurry. The reaction mixture was cooled to 30 °C before N- methylformamide (S14, 290 pL, 5.0 mmol) was added dropwise over 1 min. The mixture was stirred for 15 min before diethyl sulfate (S16, 980 pL, 7.5 mmol) was added dropwise over 1 min. The reaction mixture was stirred at 30 °C overnight. The reaction mixture was filtered through a fritted funnel into a round-bottom flask under vacuum. The filter cake was washed with additional / -BuOH (5 mL). The filtrate was sampled and analyzed to provide an assay yield of 87%.
[0098] Method 2, Preparation 3: A 500 mL jacketed reactor with a positive nitrogen inlet was charged with benzyltriethylammonium chloride (BTEAC, 13.0 g, 60.0 mmol) and / -butanol ( / -BuOH, 300 mL). The agitation rate was set as 400 rpm. The chiller’s temperature was adjusted to 15 °C before potassium hydroxide (67.3 g, 1.20 mol) was added in one portion. N- Methylformamide (35.1 mL, 600 mmol) was added via a syringe over 5 min. Diethyl sulfate (94.3 mL, 720 mmol) was dosed using a syringe pump over 2 h. During the dose, an exotherm was observed, and the internal temperature fluctuated between 17 to 25 °C. After the dose, the chiller’s temperature was raised to 25 °C, and the reaction mixture was agitated for another 2 h. The reaction mixture was drained and filtered into a round-bottom flask under vacuum.Additional / -BuOH (200 mL) was used to wash the reactor and the filter cake. The filtrate was sampled and analyzed by GC with DMF as the internal standard. The assay yield of product was determined as 78%, with 2% A-methylformamide remaining.
[0099] Method 3, Preparation 1: A round-bottom flask with a stir bar was charged with N- methylethanamine (S12, 2.96 g, 50.0 mmol). The flask was placed in an ice bath and cooled to<10 °C. Ethyl formate (S17, 3.89 g, 52.5 mmol) was slowly added via an addition funnel over 20 min, while carefully maintaining the temperature below 20 °C. The reaction mixture was warmed to ambient temperature and stirred overnight. The reaction mixture was concentrated under vacuum at 35 °C to remove ethanol. Once the mixture was concentrated, additional heptane (10 mL) was added and distilled until the heptane concentration was <5%. After concentrating, the desired product, A'-ethyl-A-methyl formamide (S13), was isolated as a paleyellow oil (3.34 g, 77% yield). Analytical data matched those above.
[0100] Method 3, Preparation 2: A 10 mL microwave reactor vial was charged with formic acid (S18, 1.84 g, 1.0 equiv, 40 mmol). The reactor vial was cooled in an ice bath before addition of A-ethylmethylamine (S12, 2.36 g, 1.0 equiv, 40 mmol) slowly over 5 min. The reactor vial was then sealed and heated at 110 °C for 24 h in a microwave reactor. After 24 h, the reactor vial was cooled and opened, yielding a colorless liquid with a 93% assay yield of S13.
[0101] Method 4, Preparation 1: To a solution of A-methylformamide (S14, 2.95 mL, 50 mmol) in THF (41.0 mL, 500 mmol) was added sodium / cv'Z-butoxide (5.29 g, 55.0 mmol). The mixture was stirred for 30 min. lodoethane (S19, 4.44 mL, 55.0 mmol) was added dropwise, and the reaction mixture was heated to 50 °C overnight. The mixture was cooled to ambient temperature, and water (25 mL) was added dropwise. Methyl / c / 7-butyl ether (MTBE, 50 mL) was added, and the layers were separated. The aqueous layer was thrice extracted with MTBE. The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under vacuum (30 °C, 26.6 kPa (200 torr)) then at 40 °C, 1.3 kPa (10 torr)) to provide A-ethyl-A'- methylformamide (S13, 1.95 g, 44.8% yield) as an orange / red oil. Analytical data matched those above.EXAMPLE 3
[0102] Synthesis ofN'-(2,5-dimethylphenyl)-N-ethyl-N-methylformimidamide (S2) or N'-(2,5- dimethylphenyl)-N-ethyl-N-methylformimidamide hydrochloride (S2-HC1)S2-HCI (HCI salt)
[0103] Preparation 1: A glass-lined reactor, equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet, under an inert atmosphere, was charged with N- ethyl-A-methylformamide (S13, 20.8 g, 93 wt %, 222 mmol) and anhydrous DCM (200 mL). The reactor jacket was set to 20 °C. Once the internal temperature was below 22 °C, oxalyl dichloride (28.8 g, 20 mL, 222 mmol) was added slowly dropwise over 30 min. After complete addition, the mixture was stirred for an additional 30 min. 2,5-Dimethylaniline (S4, 25.7 mL, 98 wt %, 202 mmol) was added slowly over 90 min. After complete addition, the mixture was stirred for an additional 2 h. The homogeneous solution was concentrated under vacuum to -150 mL. The concentrated solution was slowly added to an aqueous solution of potassium carbonate (20 wt %, 200 mL). The layers were mixed until gas evolution stopped, and the mixture was allowed to settle. The organic layer was collected, dried over sodium sulfate, filtered, and concentrated under vacuum to afford S2 neutral form (37.5 g, 93% yield) as a reddish oil: 'H NMR (500 MHz, CDCh) 5 7.40 (br, 1H), 7.01 (d, J= 7.5 Hz, 1H), 6.73 (dd, J= 7.7, 1.8 Hz, 1H), 6.57 (d, J = 1.8 Hz, 1H), 3.43 - 3.25 (br, 2H), 2.99 (s, 3H), 2.27 (s, 3H), 2.22 (s, 3H), 1.19 (t, J = 7.2 Hz, 3H);13C NMR (126 MHz, CDCh) 8 151.79, 150.54, 135.91, 129.84, 128.34, 123.11, 123.09, 120.14, 47.66 (br), 32.18 (br), 21.05, 17.62, 14.02 (br); MS (ESI) m / z calcd for Ci2Hi9N2+[M + H]+191, found 191.
[0104] Preparation 2: A solution of A-ethyl-A-methylformamide (S13, 30.6 grams, 0.35 mol) was prepared in DCM (312 g), and a separate solution of oxalyl dichloride (44.5 g, 0.35 mol) was prepared in DCM (325 g). Both solutions were loaded into a syringe pump (pump 1). A solution of 2,5-dimethylaniline (S4, 43.6 g, 0.36 mol) in DCM (750 g) was prepared and loadedinto a syringe pump (pump 2). The formamide feed rate was set to 5.0 mL / min (pump 1), and the oxalyl dichloride feed rate was set to 4.88 mL / min (pump 2). The two reagent feeds were precooled to 10 °C and combined in a static mixer to ensure proper mixing of the two components. The reagent feed was then fed continuously through a pre-cooled (10 °C) reacting zone (reactor 1) with a residence time of 1-5 min, preferably 1.9 min to produce the Vilsmeier reagent, also known as reagent V. The Vilsmeier reagent was then carried forward into the amidine formation step. The 2,5-dimethylaniline was pumped via another pump (pump 3) with a feed rate set to 11.4 mL / min. The outlet of reactor 1 (Vilsmeier reagent, reagent V) and pump 4 (2,5- dimethylaniline, S4) were fed into an additional static mixer pre-warmed to 35 °C to ensure proper mixing of the two components. The reagent feed was then fed through a pre-warmed (35 °C) reacting zone (reactor 2) with a residence time of 1.1 min to produce the product. The outlet of reactor 2 was sent to a collection vessel for gas-liquid disengagement to release the gases generated from the process, and sent to a caustic scrubber to neutralize (10 wt % sodium hydroxide). After all the formamide, oxalyl dichloride, and 2,5-dimethylaniline reagent feeds were depleted, pumps were purged and cleaned with DCM. The resulting product feed in DCM was quenched with 20 wt % potassium carbonate (150 mL). The organic and aqueous layers were separated. The organic layer was passed through a phase separator and was concentrated under vacuum. The resulting product was diluted in heptane (200 g), and the mixture was concentrated under vacuum. The process was repeated twice more to afford S2 neutral form (23.1 g, 34% yield). Analytical data matched those above.
[0105] Preparation 3: To a reactor under inert atmosphere and at ambient temperature, triphosgene (45 g, 152 mmol) and DCM (188 mL) were added, and the internal temperature was adjusted to below 20 °C. V-Ethyl-A'-rn ethylformamide (S13, 39 g, 448 mmol) was added slowly over 1.5 h, and the reaction mixture was stirred for an additional 30 min. The temperature was adjusted, and neat 2,5-dimethylaniline (S4, 50 g, 413 mmol) was added over the course of 1 h at 20 °C. The mixture was stirred for 3 h. A DCM solution of S2-HC1 (325 g, 99% yield) was taken directly into the next step without further purification.EXAMPLE 4
[0106] Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid(S5)S2 S5
[0107] To a solution of .V-(2,5-dimethylphenyl)-;V-ethyl-Af-methylformimidamide (S2, 0.26 g, 1.35 mmol) in DCM (2.17 mL, 33.8 mmol) cooled to 0 °C was added aluminum trichloride (0.36 g, 2.7 mmol). A solution of oxalyl dichloride (0.24 mL, 2.7 mmol) in DCM (0.85 mL) was added dropwise at 0 °C, and the reaction mixture was stirred for 1 h. A second portion of aluminum trichloride (0.18 g, 1.35 mmol) and oxalyl dichloride (0.12 mL, 1.35 mmol) were added, and the reaction mixture was stirred for 30 min, while slowly warming to ambient temperature. Sodium sulfate decahydrate (6.53 g, 20.3 mmol) was placed in a 125 mL Erlenmeyer flask equipped with a stir bar with DCM (50 mL). The reaction mixture was then pipetted into the flask and the reaction vessel was washed twice with DCM and once with EtOAc. The mixture was allowed to stir until the DCM turned clear yellow (~30 min) before the reaction mixture was poured through a phase separator. This left the solid decahydrate and residue. The extracted DCM was set off to the side. The residue was dissolved in a 1 : 1 mix of methanol-ethanol, and the solution was poured through a phase separator. The flask and the phase separator were washed with the alcohol mixture, and the combined alcoholic organic layers were concentrated under vacuum to provide the product as an oil, which was subsequently purified by column chromatography to afford the title compound (S5, 329 mg, 87%) as a solid. Analytical data matched literature.EXAMPLE 5
[0108] Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1)
[0109] In a flask, equipped with a stir bar and a reflux condenser with an outlet to a base scrubber, was added A-ethyl-V-methylformamide (S13, 7.83 g, 1.10 equiv, 89.9 mmol) and DCM (60.0 mL). To this solution was added oxalyl dichloride (11.0 g, 1.05 equiv, 85.8 mmol) at ambient temperature over 30 min using a syringe pump. The stirring was continued for an additional 30 min. 2,5-Dimethylaniline (S4, 10.0 g, 1 equiv, 81.7 mmol) was added to this solution dropwise over 90 min while maintaining the reaction at ambient temperature. After the addition was complete, the stirring was continued for an additional 1 h. A small aliquot of the reaction showed >99% conversion via HPLC. In a separate 500 mL flask equipped with a stir bar, a condenser with an outlet line attached to the base scrubber was added aluminum trichloride (33.6 g, 3.05 equiv, 249 mmol). The flask was evacuated and backfilled with nitrogen (3 times), DCM (60 mL) was added to the flask under nitrogen, and the flask was cooled to 0 °C. Oxalyl dichloride (21.3 g, 14.4 mL, 2.05 equiv, 167 mmol) was added dropwise at 0 °C to this mixture over 30 min using a syringe pump. The contents of the flask were stirred at 0 °C for an additional 30 min. The amidine solution prepared in the first step was added dropwise over 3 h at 0 °C to this mixture. After the addition was complete, the contents were stirred for 12 h at 0 °C, or until HPLC analysis showed >98% conversion. In another 1 L four-neck flask equipped with a stir bar, short path condenser, a reflux condenser with an outlet line attached to a base scrubber, and a temperature probe was added 4 N HC1 (306 mL). The flask was heated to 40 °C and the solution of acid chloride prepared above was added dropwise over a period of 3 h using a peristaltic pump. DCM was distilled (126 g) during the addition. After the addition was complete, the contents of the flask were stirred at 40 °C for 1 h and then cooled to ambient temperature for 1 h. The solids were filtered and washed with 4 N HC1 (25 mL x 2). The solids were dried over 1 h and washed with acetone (10 mL x 3). The solids were dried again over 2 h. The solids were collected to afford the title compound (S5-HC1, 18.6 g, 84% yield) as an off-white solid: 'H NMR (500 MHz, DMSO-cfc, mixture of rotamers) 5 12.95 (s, 1H), 11.69 - 11.16 (m, 1H), 8.57 - 8.34 (m, 1H), 7.75 (s, 1H), 7.39 - 7.30 (m, 1H) 3.82 (q, J= 7.1 Hz, 1H), 3.66 (q, J= 7.1 Hz, 1H), 3.37 - 3.29 (m, 3H), 3.32 (d, J= 10.7 Hz, 3H), 2.51 (s, 3H), 2.38 (s, 3H), 1.26 (dt, J= 13.1, 7.1 Hz, 3H);13C NMR (126 MHz, DMSO-c / r,, mixture of rotamers) 5 167.93, 155.25, 155.06, 138.96, 138.05, 132.89, 132.84, 129.93, 129.66, 129.20, 129.12, 127.38, 127.12, 51.09, 44.57, 40.67, 35.06, 20.71, 17.20, 17.17, 13.10, 10.90; MS (ESI) m / z calcd for Ci3Hi9N2O2+[M+ H]+235, found 235.EXAMPLE 6
[0111] Step 1 - Amidination of 2 f -dimethylaniline: A glass-lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was charged with N- ethyl-A-methylformamide (S13, 8.63 g, 99.0 mmol, 1.2 equiv) and anhydrous DCM (100 m ) under inert atmosphere. The reactor jacket was set to 20 °C, and the mixture was stirred at 350 rpm. Once the internal temperature was < 22 °C, oxalyl dichloride (12.0 g, 8.14 mL, 94.9 mmol, 1.15 equiv) was added over 30 min using a syringe pump. After complete addition, the mixture was stirred for an additional 30 min. Neat 2,5-dimethylaniline (S4, 10.0 g, 82.5 mmol, 1 equiv) was added over 90 min using a syringe pump. After complete addition, the mixture was stirred for an additional 1 h. The mixture was analyzed by HPLC, showing full conversion. This solution of S2-HC1 was used in the next step without any further purification:1H NMR (400 MHz, CD3OD, mixture of rotamers) 8 8.32 (s, 1H), 8.18 (s, 1H), 7.22 (d, J= 7.4 Hz, 3H), 7.20 - 7.08 (m, 6H), 3.72 (qd, J= 7.3, 3.4 Hz, 4H), 3.40 (d, J= 2.4 Hz, 3H), 3.36 - 3.27 (m, 3H), 2.39 - 2.31 (m, 12H), 1.39 (tt, J= 7.1, 2.9 Hz, 6H);13C NMR (101 MHz, CD3OD, mixture of rotamers) 8 155.43, 155.33, 137.53, 137.32, 137.29, 135.69, 135.63, 130.86, 130.82, 129.75, 129.54,128.91, 128.84, 128.56, 127.85, 125.14, 124.99, 124.94, 53.50, 51.70, 44.36, 40.32, 33.55, 20.12, 19.44, 15.89, 15.84, 12.53, 12.39, 9.81; MS (ESI) m / z calcd for CI2HI9N2+[M + H]+191, found 191.
[0112] Step 2 - General procedure for synthesis of ester HCl salts: A glass-lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was charged with aluminum trichloride (33.0 g, 247 mmol, 3 equiv) and DCM (100 mL) under inert atmosphere. The reactor jacket was set to 0 °C, and the mixture was stirred. Once the internal temperature was < 2 °C, oxalyl dichloride (21.0 g, 165 mmol, 2 equiv) was added over 30 min using a syringe pump. The contents were stirred below 2 °C for an additional 1 h. The solution prepared in Step 1 was then added over a period of 3 h using a syringe pump while maintaining the internal temperature below 2 °C. After the addition was complete, the contents were stirred for an additional 2 h at < 2 °C. A small aliquot of the reaction mixture was quenched with alcohol and analyzed by HPLC which indicated full conversion to ester. The required alcohol (20 equiv) was added dropwise over 30 min at 0 °C to the solution. The contents of the flask were stirred at 0 °C to ambient temperature over 12 h. 2 N HCl (100 mL) was added to the reaction mixture over 20 min at 0 °C. The reaction mixture was warmed to ambient temperature and was stirred for 1 h. The contents of the flask were partitioned in a separatory funnel. The organic layer was separated and if required additional back extractions may be conducted with DCM. The combined organic layers were concentrated under vacuum to afford the desired product S3- HC1
[0113] Ethyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3b-HCl, 23.3 g, 94% yield) was prepared using the representative procedure above and was isolated as a light yellow solid:1H NMR (400 MHz, CDCI3, mixture of rotamers) 8 12.31 (dd, J= 24.5, 13.0 Hz, 1H), 8.04 (dd, J = 23.6, 12.9 Hz, 1H), 7.71 (d, J = 3.5 Hz, 1H), 7.28 (s, 1H), 4.59 (s, 1H), 4.33 (q, J= 7.1 Hz, 2H), 4.00 (q, J= 7.2 Hz, 1H), 3.68 (q, J= 7.2 Hz, 2H), 3.49 (s, 2H), 3.36 (s, 1H), 2.49 (s, 3H), 2.45 (s, 3H), 1.38 (t, J = 7.2 Hz, 3H), 1.32 (t, J= 7.2 Hz, 3H);13C NMR (101 MHZ, CDCI3, mixture of rotamers) 8 166.80, 154.17, 154.10, 139.25, 138.80, 138.73, 133.55, 133.48, 130.31, 130.10, 129.24, 127.28, 127.19, 76.75, 60.93, 52.34,46.40, 41.57, 36.90, 21.02, 18.04, 14.30, 13.55, 11.34; MS (ESI) m.'z calcd for CisIfe^C [M+ H]+263, found 263.
[0114] Propyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3c-HCl, 21.0 g, 81% yield) was prepared using the representative procedure above and was isolated as an off-white solid:!H NMR (400 MHz, CDCh, mixture of rotamers) 8 12.41 (dd, J= 16.1, 13.1 Hz, 1H), 8.15 (dd, J= 23.9, 12.9 Hz, 1H), 7.70 (d, J= 3.5 Hz, 1H), 7.23 (d, J= 15.4 Hz, 1H), 4.22 (t, J= 6.7 Hz, 2H), 4.01 (q, J= 7.2 Hz, 1H), 3.70 (q, J= 7.2 Hz, 1H), 3.49 (s, 2H), 3.36 (s, 1H), 2.50 - 2.41 (m, 6H), 1.77 (hept, J= 7.1 Hz, 2H), 1.31 (t, J= 1A Hz, 3H), 1.01 (t, J = 7.4 Hz, 3H);13C NMR (101 MHz, CDCh, mixture of rotamers) 8 166.91, 154.24, 139.16, 138.69, 133.58, 133.51, 130.17, 129.34, 127.48, 127.37, 66.61, 52.26, 46.44, 41.50, 36.96, 22.05, 21.08, 18.11, 13.60, 11.37, 10.60; MS (ESI) m / z calcd for CI6H25N2O2+[M + H]+277, found 277.
[0115] Isopropyl 4-(((ethyl (methyl )amino)methylene)amino)-2, 5 -dimethylbenzoate hydrochloride (S3a-HCl, 22.9 g, 86% yield) was prepared using the representative procedure above and was isolated as a light yellow solid:1H NMR (400 MHz, CDCI3, mixture of rotamers) 8 12.30 (dd, J = 17.6, 12.9 Hz, 1H), 8.21 (dd, J= 24.1, 12.9 Hz, 1H), 7.65 (d, J= 3.4 Hz, 1H), 7.20 (d, J= 15.0 Hz, 1H), 5.18 (hept, J= 6.3 Hz, 1H), 3.97 (q, J= 7.2 Hz, 1H), 3.70 (q, J= 7.2 Hz, 1H), 3.46 (s, 2H), 3.35 (s, 1H), 2.47 (s, 3H), 2.42 (s, 2H), 1.32 (dd, J= 17.8, 6.6 Hz, 9H);13C NMR (101 MHZ, CDCI3, mixture of rotamers) 8 166.46, 166.44, 154.31, 154.17, 138.87, 138.84, 138.56, 138.50, 133.41, 133.34, 130.36, 130.14, 129.83, 127.51, 127.39, 76.78, 68.50, 52.18, 46.37, 41.44, 36.87, 21.94, 21.01, 18.06, 13.60, 11.34; MS (ESI) TW / Z calcd for Ci6H25N2O2+[M + H]+277, found 277.
[0116] Butyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3d-HCl, 24.2 g, 90% yield) was prepared using the representative procedure above and was isolated as a dark red oil: 'H NMR (400 MHz, CDCh, mixture of rotamers) 8 8.27 (s, 1H), 8.19 (s, 1H), 7.65 (d, J= 3.0 Hz, 1H), 7.24 (s, 1H), 4.24 (t, J= 6.7 Hz, 2H), 3.90 (q, J= 12 Hz, 1H), 3.68 (q, J= 12 Hz, 1H), 3.38 (s, 2H), 3.32 (s, 1H), 2.45 (s, 3H), 2.37 (d, J= 2.3 Hz, 3H), 1.70 (dq, J= 8.7, 6.8 Hz, 2H), 1.49 - 1.35 (m, 2H), 1.25 (td, J= 12, 2.4 Hz, 4H), 0.94 (t, J= 7.4 Hz, 3H);13C NMR (101 MHz, CDCh, mixture of rotamers) 8 171.69, 166.94, 154.31,154.16, 139.15, 138.59, 133.44, 133.36, 130.18, 129.96, 129.21, 127.39, 127.26, 72.74, 64.84, 52.17, 46.14, 41.44, 36.54, 31.83, 30.69, 22.65, 21.00, 19.28, 17.95, 14.08, 13.72, 13.48, 11.20; MS (ESI) m / z calcd for Ci7H27N2O2+[M + H]+291, found 291.
[0117] Sec-butyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3e-HCl, 6.8 g, 65% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5-dimethylaniline, and was isolated as a dark red oil: 'H NMR (400 MHz, CDCh, mixture of rotamers) 8 12.45 (s, 1H), 8.20 (s, 1H), 7.70 (d, J= 3.2 Hz, 1H), 7.22 (d, J= 14.9 Hz, 1H), 5.06 (hept, J= 6.3 Hzm, 1H), 4.01 (q, J= 7.0 Hz, 1H), 3.71 (q, J= 7.2 Hz, 1H), 3.50 (s, 2H), 3.37 (s, 1H), 2.50 (s, 3H), 2.46 (s, 2H), 1.82 - 1.58 (m, 2H), 1.32 (dd, J = 8.4, 6.3 Hz, 6H), 0.97 (t, J= 7.4 Hz, 3H);13C NMR (101 MHz, CDCh, mixture of rotamers) 8 166.61, 154.25, 154.11, 138.93, 138.91, 138.70, 133.46, 133.38, 130.44, 130.23, 129.87, 127.52, 127.42, 77.32, 73.06, 52.21, 46.42, 41.46, 36.95, 28.90, 21.10, 19.55, 18.14, 13.66, 11.40, 9.82; HRMS (ESI) m / z calcd for Ci7H27N2O2+[M + H]+291.2067, found 291.2063.
[0118] Isobutyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3f-HCl, 9.6 g, 85% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5-dimethylaniline, and was isolated as a light yellow solid:1H NMR (400 MHz, CDCh, mixture of rotamers) 8 12.41 (t, J = 14.6 Hz, 1H), 8.22 (dd,23.9, 12.6 Hz, 1H), 7.72 (d, J= 3.5 Hz, 1H), 7.25 (d, J= 15.9 Hz, 1H), 4.10 - 3.96 (m, 2H), 3.72 (q, J = 7.1 Hz, 1H), 3.50 (s, 2H), 3.38 (s, 1H), 2.52 - 2.43 (m, 5H), 2.07 (hept, J = 6.7 Hz, 1H), 1.32 (t, J= 6.8 Hz, 3H), 1.02 (d, J= 6.7 Hz, 6H);13C NMR (101 MHz, CDCh, mixture of rotamers) 8 166.92, 154.34, 154.21, 139.15, 139.12, 138.78, 138.72, 133.61, 133.53, 130.42, 130.21, 129.37, 127.59, 127.47, 77.32, 71.18, 52.26, 46.47, 41.52, 36.99, 27.83, 21.17, 19.30, 18.18, 13.64, 11.40; HRMS (ESI) m / z calcd for Ci7H27N2O2+[M + H]+291.2067, found 291.2063.
[0119] Pentyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3g-HCl, 7.5 g, 79% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5-dimethylaniline, and was isolated as a yellow solid:1H NMR (400 MHz, CDCh, mixture of rotamers) 8 12.40 (s, 1H), 8.05 (s, 1H), 7.73 (d, J= 3.4 Hz, 1H), 7.26 (d, J= 10.7 Hz, 1H), 4.27 (t, J= 6.8 Hz, 2H), 4.04 (q, J= 7.2 Hz, 1H), 3.69 (q, J= 7.2 Hz, 2H), 3.53 (s, 2H), 3.38 (s, 1H), 2.49 (d, J= 14.7 Hz, 6H), 1.76 (p, J= 7.0 Hz, 2H), 1.48 - 1.31(m, 8H), 0.99 - 0.90 (m, 3H);13C NMR (101 MHz, CDCh, mixture of rotamers) 6 166.92, 154.08, 154.02, 139.24, 139.21, 138.77, 138.71, 133.64, 133.57, 130.42, 130.21, 129.43, 127.38, 127.29, 77.27, 65.21, 52.39, 46.48, 41.60, 37.01, 28.35, 28.21, 22.32, 21.10, 18.09, 13.98, 13.59, 11.37; HRMS (ESI) m / z calcd for Ci8H29N2O2+[M+H]+305.2224, found 305.2218.
[0120] Isopentyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3h-HCl, 8.0 g, 68% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5-dimethylaniline, and was isolated as a light yellow solid:1H NMR: (400 MHz, CDCh, mixture of rotamers) 8 12.76 (d, J= 14.3 Hz, 1H), 7.90 (dd, J= 25.7, 12.1 Hz, 1H), 7.73 (d, <7= 3.2 Hz, 1H), 7.25 (d, J= 13.0 Hz, 1H), 4.31 (t, .7= 6.9 Hz, 2H), 4.10 (q, J= 7 A Hz, 1H), 3.67 (q, J= 7.2 Hz, 2H), 3.58 (s, 2H), 3.37 (s, 1H), 2.50 (d, J= 4.4 Hz, 6H), 1.77 (dp, <7= 13.2, 6.6 Hz, 1H), 1.66 (q, J= 6.9 Hz, 2H), 1.42 - 1.32 (m, 3H), 0.98 (d, J= 6.6 Hz, 6H);l3C NMR: (101 MHz, CDCh, mixture of rotamers) 8 164.83, 151.90, 151.84, 137.23, 137.20, 136.83, 136.77, 131.67, 131.60, 128.49, 128.28, 127.40, 125.32, 125.25, 75.21, 61.69, 50.40, 44.62, 39.60, 35.33, 35.20, 23.21, 20.47, 19.09, 16.15, 11.59, 9.42; HRMS (ESI) m r calcd for CISH29N2O2+[M+H]+305.2224, found 305.2219.
[0121] 2-Ethylhexyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3i-HCl) was prepared by a modified procedure: 10 equiv of 2-ethylhexanol were used instead of 20 equiv as described in the general procedure. After the acidic quench and extraction with 2 N HC1, the organic phase was concentrated to provide a yellow oil. The oil was taken up in ethyl acetate (100 mL) and basified with 2 NNaOH until pH >9. The resulting solution was stirred for 20 min before being separated. The organic phase was washed with brine (20 mL) and concentrated to provide a yellow oil. The resulting neutral form was purified via column chromatography, eluting in 10-15% ethyl acetate in hexanes. Five iterations of column chromatography were required to remove any residual alcohol present. The resulting pure fractions were concentrated to provide 2-ethylhexyl 4-(((ethyl(methyl)amino)methylene)amino)- 2,5-dimethylbenzoate (S3i, 1.0 g, 2.7 mmol, 8.3% yield, 95% purity) as a clear colorless oil. 2- Ethylhexyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (500 mg, 1.35 mmol) prepared above was taken up in 40 mL DCM and acidified with 2 N HC1 until pH <2. The resulting solution was stirred for 20 min before being transferred to a separatory funnel. Thelayers were separated and then the organic phase was concentrated under vacuum to afford 2- ethylhexyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (580.0 mg, 86% yield) as a light yellow, waxy solid:(400 MHz, CDCh, mixture of rotamers) 8 7.91 (d, J= 29.0 Hz, 1H), 7.71 (s, 1H), 7.17 (s, 1H), 4.18 (d, J= 5.7 Hz, 2H), 3.97 (s, 1H), 3.62 (s, 1H), 3.47 (s, 2H), 3.31 (s, 1H), 2.49 (s, 3H), 2.44 (s, 3H), 1.68 (p, J= 6.1 Hz, 1H), 1.42 (p, . / = 7,0 Hz, 2H), 1.38 - 1.23 (m, 9H), 0.90 (dt, J= 13.2, 7.0 Hz, 6H);13C NMR (101 MHz, CDCh, mixture of rotamers) 8 167.13, 153.87, 139.19, 133.59, 130.16, 128.83, 126.85, 77.27, 67.34, 51.97, 38.86, 36.70, 30.58, 28.96, 24.00, 22.97, 21.27, 18.15, 14.05, 13.74, 11.06; HRMS (ESI) m / z calcd for C2iH35N2O2+[M+H]+: 347.2693, found 347.2688.
[0122] Methyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3j-HCl) was prepared in accordance with general procedure with modification in step 2 (below).
[0123] Step 2. A glass-lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was charged with aluminum trichloride (33.0 g, 247 mmol, 3 equiv) and DCM (100 mb) under inert atmosphere. The reactor j acket was set to 0 °C, and the mixture was stirred at 350 rpm. Once the internal temperature was < 2 °C, oxalyl dichloride (21.0 g, 165 mmol, 2 equiv) was added over 30 min using a syringe pump. The contents were stirred below 2 °C for an additional 1 h. The solution prepared in Step 1 was then added over a period of 3 h using a syringe pump while maintaining the internal temperature below 2 °C. After the addition was complete, the contents were stirred for an additional 2 h at < 2 °C. A small aliquot of the reaction mixture was quenched with alcohol and analyzed by HPLC which indicated full conversion to ester. MeOH (52.9 g, 66.8 m , 20 equiv, 1650 mmol) was added below 0 °C dropwise using a syringe pump. After the addition was complete, the contents were stirred at 0 °C for 1 h then warmed to 25 °C and stirred for 8 hours. The reaction mixture was diluted with DCM (200 mL) at 25 °C and stirred for 10 min. The contents of the reactor were then filtered through a Buchner funnel packed with Celite®. The Celite® bed was washed thoroughly with additional DCM (30 mL x 3). The combined filtrates were concentrated under reduced pressure (final weight = 50 g) and diluted with EtOAc (100 mL). The mixture was concentrated under reduced pressure to final weight of 40 g of semisolid material. AdditionalEtOAc (100 mL) was added to the semisolid material. Solids started precipitating. The flask was cooled to 0 °C, and the contents were stirred for 2 h at 0 °C. The solids were filtered and washed with EtOAc (3 x 10 mL) and dried under vacuum to afford the desired product, methyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3j-HCl, 20.22 g, 86% yield, 94% purity) as an off-white solid. 'H NMR (400 MHz, CDiOD, mixture of rotamers) 8 8.46 (s, 1H), 7.86 (s, 1H), 7.34 (d, J= 3.8 Hz, 1H), 3.90 (d, J= 2.4 Hz, 3H), 3.78 (dd, J= 9.4, 4.8 Hz, 3H), 3.44 (s, 1H), 3.36 (s, 3H), 2.59 (s, 3H), 2.42 (s, 4H), 1.41 (t, J= 7.2 Hz, 4H);13C NMR (101 MHZ, CD3OD, mixture of rotamers) 8 167.22, 155.27, 155.22, 139.38, 139.35, 138.80, 138.73, 133.18, 133.13, 130.01, 129.75, 129.13, 129.01, 127.09, 126.86, 52.02, 51.16, 44.64, 40.58, 33.83, 19.83, 15.91, 15.86, 12.33, 9.87; MS (ESI) m / z calcd for Ci4H2iN2O2+[M + H]+249, found 249.EXAMPLE 7
[0125] Step 1 - Amidination of 2,5-dimethylaniline: A glass-lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was charged with N- ethyl-A-methylformamide (S13, 8.63 g, 99.0 mmol, 1.2 equiv) and anhydrous DCM (100 mL) under inert atmosphere. The reactor jacket was set to 20 °C, and the mixture was stirred at 350 rpm. Once the internal temperature was < 22 °C, oxalyl dichloride (12.0 g, 8.14 mL, 94.9 mmol, 1.15 equiv) was added dropwise over 30 min using a syringe pump. After complete addition, the mixture was stirred for an additional 30 min. Neat 2,5-dimethylaniline (S4, 10.0 g, 82.5 mmol, 1 equiv) was added over 90 min using a syringe pump. After complete addition, the mixture was stirred for an additional 1 h. The mixture was analyzed by HPLC, showing full conversion. This solution of S2-HC1 was used in the next step without any further purification.
[0126] Step 2 - General procedure for synthesis of ester HCl salts: A glass-lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was charged with aluminum trichloride (33.0 g, 247 mmol, 3 equiv) and DCM (100 mL) under inert atmosphere. The reactor jacket was set to 0 °C and the mixture stirred at 350 rpm. Once the internal temperature was < 2 °C, oxalyl di chloride (21.0 g, 165 mmol, 2 equiv) was added over 30 min using a syringe pump. The contents were stirred below 2 °C for an additional 1 h. The solution prepared in Step 1 was then added over a period of 3 h using a syringe pump while maintaining the internal temperature below 2 °C. After the addition was complete, the contents were stirred for an additional 2 h at < 2 °C. A small aliquot of the reaction mixture was quenched with alcohol and analyzed by HPLC which indicated full conversion to ester. The required alcohol (20 equiv) was added dropwise over 30 min at 0 °C to the solution. The contents of the flask were stirred at 0 °C to ambient temperature over 12 h. 2 N HCl (100 mL) was added to the reaction mixture over 20 min at 0 °C. The reaction mixture was warmed to ambient temperature and was stirred for 1 h. The contents of the flask were partitioned in a separatory funnel. The organic layer was separated and if required additional back extractions may be conducted with DCM. The combined organic layers were concentrated under vacuum.
[0127] Step 3 - General procedure for synthesis of ester neutral forms: The salt from Step 2 was diluted with additional DCM (4 vol). The mixture was quenched by dropwise addition of 2 N NaOH solution (5 vol) at 0 °C for 2 h while maintaining the pH above 8-9. The mixture was stirred for 30 min at 0 °C and was warmed to ambient temperature for 1 h. The mixture was then transferred to a separatory funnel. The bottom organic layer was separated and concentrated under vacuum to afford the desired product S3.
[0128] Ethyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3b, 1.54 g, 87% yield) was prepared using the representative procedure above, but starting from 2.07 g S3b- HC1 in Step 3, and was isolated as a dark red oil: 'H NMR (400 MHz, CDCI3) 8 7.77 (s, 1H), 7.50 (s, 1H), 6.62 (s, 1H), 4.33 (q, J= 1A Hz, 2H), 3.57 (s, 1H), 3.37 (s, 1H), 3.08 (s, 3H), 2.56 (s, 3H), 2.28 (s, 3H), 1.40 (t, J= 7.1 Hz, 3H), 1.25 (t, J= 7.2 Hz, 3H);13C NMR (101 MHz, CDCh) 8 167.72, 151.91, 139.24, 132.73, 128.91, 122.39, 60.18, 21.67, 17.48, 14.44; MS (ESI) m / z calcd for CISH23N2O2+[M+H]+263, found 263.
[0129] Propyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3c, 1.55 g, 89% yield) was prepared using the representative procedure above, but starting from 1.98 g S3c-HCl in Step 3, and was isolated as a dark red oil: 'H NMR (400 MHz, CDCh) 8 7.78 (s, 1H), 7.49 (s, 1H), 6.60 (s, 1H), 4.24 (t, J= 6.7 Hz, 2H), 3.44 (d, J= 67.9 Hz, 2H), 3.04 (s, 3H), 2.56 (s, 3H), 2.27 (s, 3H), 1.79 (p, J = 7.1 Hz, 2H), 1.26 (dt, J= 14.3, 7.1 Hz, 4H), 1.05 (t, J = 7.4 Hz, 3H);13C NMR (101 MHz, CDCh) 8 (ppm) 166.90, 154.19, 154.08, 139.17, 139.14, 138.77, 138.71, 133.60, 133.53, 130.40, 130.19, 129.36, 127.45, 127.35, 66.61, 52.28, 46.47, 41.52, 37.00, 22.05, 21.09, 18.12, 13.60, 11.38, 10.61; MS (ESI) m / z calcd for Ci6H25N2O2+[M+H]+277, found 277.
[0130] Isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3a, 0.71 g, 79% yield) was prepared using the representative procedure for Step 2 above, but starting from 1.05 g S3a-HCl in Step 3, and was isolated as a dark red oil: ’H NMR (400 MHz, CDCh) 8 7.75 (s, 1H), 7.48 (s, 1H), 6.59 (s, 1H), 5.21 (h, J = 6.2 Hz, 1H), 3.52 (s, 1H), 3.35 (s, 2H), 3.04 (s, 3H), 2.56 (s, 3H), 2.27 (s, 3H), 1.37 (d, J= 6.3 Hz, 6H), 1.24 (t, J= 7.1 Hz, 3H);13C NMR (101 MHz, CDCh) 8 167.37, 154.00, 151.81, 139.00, 132.59, 128.77, 123.57, 122.07, 67.38, 47.94, 32.12, 22.09, 21 .74, 17.44; MS (ESI) m / z calcd for CI6H25N2O2+[M+H]+277, found 277.
[0131] Butyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3d) was prepared by a modified procedure for Step 3: The resultant S3d-HCl (220 g) was dissolved in water (1650 mL, 7.5 vol). The aqueous layer was washed with MTBE (440 mL, 2 vol x 2). The aqueous layer was neutralized (pH 7-8) with saturated sodium bicarbonate solution and was extracted with ethyl acetate (660 mL, 3 vol x 3). The combined ethyl acetate layers were washed with saturated sodium bicarbonate solution (440 mL, 2 vol x 2). The ethyl acetate layer was dried over sodium sulfate and was concentrated at 45 °C under vacuum to obtain butyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3d, 93 g, 48% yield) as a dark brown liquid: ’H NMR (400 MHz, CDCh) 8 7.67 (s, 1H), 6.49 (s, 1H), 4.18 (t, J= 6.6 Hz, 2H), 3.41 (s, 1H), 3.24 (s, 1H), 2.93 (s, 3H), 2.46 (s, 3H), 2.17 (s, 3H), 1.66 (p, J = 6.8 Hz, 2H), 1.40 (dt, J= 14.9, 7.4 Hz, 2H), 1.13 (t, J= 7.1 Hz, 3H), 0.90 (t, J= 7.4 Hz, 3H);13C NMR (101 MHz, CDCh) 8 171.12, 167.87, 154.33, 151.78, 139.21, 132.67, 128.77, 122.98, 121.99, 64.09, 62.62,60.38, 34.89, 30.93, 21.78, 21.03, 19.41, 18.92, 17.47, 14.20, 13.87, 13.81; MS (ESI) m / z calcd for CI7H27N2O2+[M+H]+291, found 291.
[0132] Sec-butyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3e, 3.4 g, 73% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5- dimethylaniline (S4) in Step 1, and was isolated as an orange oil:3H NMR (400 MHz, CDCh) 57.74 (s, 1H), 7.45 (s, 1H), 6.56 (s, 1H), 5.05 (h, J= 62 Hz, 1H), 3.39 (d, J= 59.0 Hz, 2H), 3.00 (s, 3H), 2.54 (s, 3H), 2.25 (s, 3H), 1.82 - 1.57 (m, 2H), 1.32 (d, J= 62 Hz, 3H), 1.21 (t, J = 12 Hz, 3H), 0.97 (t, J = 7.4 Hz, 3H);13C NMR (101 MHz, CDCh) 5 165.77, 152.65, 150.03, 137.32, 130.84, 127.00, 121.66, 120.21, 75.54, 74.04, 70.17, 46.07, 39.83, 30.24, 27.33, 27.24, 26.83, 20.08, 17.94, 17.43, 15.73, 12.57, 9.59, 8.17, 7.85; HRMS (ESI) m / z calcd C17H27N2O21[M+H]+291.2067, found 291.2062.
[0133] Isobutyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3f, 3.1 g, 83% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5- dimethylaniline (S4) in Step 1, and was isolated as an orange oil: ’H NMR (400 MHz, CDCh) 5 7.77 (s, 1H), 7.46 (s, 1H), 6.57 (s, 1H), 4.04 (d, J = 6.6 Hz, 2H), 3.40 (d, J = 692 Hz, 3H), 3.00 (s, 3H), 2.55 (s, 3H), 2.25 (s, 3H), 2.07 (dp, J = 13.4, 6.6 Hz, 1H), 1.21 (t, J= 7.2 Hz, 3H), 1.02 (d, J = 62 Hz, 6H);13C NMR (101 MHz, CDCh) 8 167.66, 154.32, 151.56, 139.03, 132.50, 128.58, 122.71, 121.74, 77.11, 72.51, 70.28, 53.25, 47.61, 41.41, 37.29, 31.76, 27.75, 21.68, 19.20, 17.31, 14.11, 14.01; HRMS (ESI) m / z calcd for CI7H27N2O2+[M+H]+291.2067, found 291.2063.
[0134] Pentyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3g, 3.4 g, 90% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5- dimethylaniline (S4) in Step 1, and was isolated as an orange oil: 'H NMR (400 MHz, CDCh) 87.75 (s, 1H), 7.46 (s, 1H), 6.57 (s, 1H), 4.25 (t, J = 62 Hz, 2H), 3.42 (dd, J = 88.1, 21.3 Hz, 2H), 3.00 (s, 3H), 2.55 (s, 3H), 2.25 (s, 3H), 1.75 (p, J= 6.9 Hz, 2H), 1.41 (dddd, J = 10.8, 8.1, 6.5, 2.1 Hz, 4H), 1.20 (t, J = 7.1 Hz, 3H), 0.93 (t, J= 6.9 Hz, 3H);13C NMR (101 MHz, CDCh) 8 166.52, 153.14, 150.40, 137.87, 131.32, 127.41, 121.57, 120.57, 75.98, 65.77, 63.02, 46.45, 36.12, 31.16, 30.60, 27.21, 27.00, 26.63, 26.49, 21.05, 20.45, 16.13, 12.96, 12.67; HRMS (ESI) m / z calcd for CISH29N2O2+[M+H]+305.2224, found 305.2218.
[0135] Isopentyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3h, 3.2 g, 85% yield) was prepared using the representative procedure above, but starting from 4.0 g 2,5- dimethylaniline (S4) in Step 1, and was isolated as an orange oil:!H NMR (400 MHz, CDCh) 5 7.75 (s, 1H), 7.46 (s, 1H), 6.56 (s, 1H), 4.28 (t, J= 6.9 Hz, 2H), 3.40 (d, J= 69.4 Hz, 2H), 3.00 (s, 3H), 2.54 (s, 3H), 2.25 (s, 3H), 1.79 (dp, J= 13.3, 6.7 Hz, 1H), 1.65 (q, J= 6.8 Hz, 2H), 1.20 (t, J= 1A Hz, 3H), 0.97 (d, = 6.6 Hz, 6H);13C NMR (101 MHz, CDCh) 5 167.61, 154.25, 151.51, 138.99, 132.42, 128.52, 122.63, 121.68, 77.08, 62.61, 47.57, 37.35, 31.71, 25.01, 22.32, 21.56, 17.24, 13.97; HRMS (ESI) m z calcd for CISH29N2O2+[M+H]+305.2224, found 305.2219.
[0136] 2-Ethylhexyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3i) was prepared by a modified procedure: 10 equiv of 2-ethylhexanol were used instead of 20 equiv as described in the original procedure. After the acidic quench and extraction with 2 N HC1, the organic phase was separated and concentrated under vacuum to provide a yellow oil. The oil was taken up in ethyl acetate and basified with 2 N NaOH until pH >9. The resulting solution was stirred for 20 min before being separated. The organic phase was washed with brine (20 mL) and concentrated under vacuum to provide a yellow oil. The resulting neutral form was purified via column chromatography. The resulting pure fractions were concentrated under vacuum to provide 2-ethylhexyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3i, 1.0 g, 8.3% yield, 95% purity) as a clear, colorless oil:1H NMR (400 MHz, CDCh) 5 7.75 (s, 1H), 7.46 (s, 1H), 6.57 (s, 1H), 4.18 (d, J= 5.7 Hz, 2H), 3.56 - 3.27 (m, 2H), 3.01 (s, 3H), 2.55 (s, 3H), 2.25 (s, 3H), 1.70 (p, J= 6.1 Hz, 1H), 1.53 - 1.25 (m, 7H), 1.22 (t, J = 7.2 Hz, 3H), 0.93 (dq, J= 14.6, 6.7 Hz, 8H);13C NMR (101 MHz, CDCh) 5 167.57, 154.04, 151.31, 138.77, 132.30, 128.33, 122.58, 121.50, 76.79, 66.19, 38.55, 34.24, 31.16, 30.26, 29.72, 28.60, 24.85, 23.65, 22.94, 22.58, 22.22, 21.42, 20.26, 17.06, 13.68, 13.62, 10.67; HRMS (ESI) m,'z calcd for C2IH35N2O2+[M+H]+347.2693, found 347.2688.
[0137] Methyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3j) was prepared in accordance with the general procedure with modification in step 2 (below).
[0138] Step 2. A glass-lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was charged with aluminum trichloride (33.0 g, 247 mmol, 3 equiv) and DCM (100 mL) under inert atmosphere. The reactor jacket was set to 0 °C, and themixture was stirred at 350 rpm. Once the internal temperature was < 2 °C, oxalyl dichloride (21.0 g, 165 mmol, 2 equiv) was added over 30 min using a syringe pump. The contents were stirred below 2 °C for an additional 1 h. The solution prepared in Step 1 was then added over a period of 3 h using a syringe pump while maintaining the internal temperature below 2 °C. After the addition was complete, the contents were stirred for an additional 2 h at < 2 °C. A small aliquot of the reaction mixture was quenched with alcohol and analyzed by HPLC which indicated full conversion to ester. MeOH (52.9 g, 66.8 mL, 20 equiv, 1650 mmol) was added below 0 °C dropwise using a syringe pump. After the addition was complete, the contents were stirred at 0 °C for 1 h before being warmed to 25 °C and stirred for 8 h. The reaction mixture was diluted with DCM (200 mL) at 25 °C and stirred for 10 min. The contents of the reactor were then filtered through a Buchner funnel packed with Celite®. The Celite® bed was washed thoroughly with additional DCM (30 mL x 3). The combined filtrates were added over 2 h to a 2 N sodium hydroxide solution at 0 °C, and the mixture was stirred for 1 h. The mixture was then transferred to a separatory funnel and allowed to phase separate (5-10 min). The lower organic layer was separated, and the top organic layer was extracted with DCM (50 mL). The combined organic layers were concentrated under reduced pressure to afford the desired product, 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3j, 18.2g, 88% yield, 95% purity); as a dark red oil. ’H NMR (400 MHz, CDC13) 8 7.68 (s, 1H), 7.39 (s, 1H), 6.50 (s, 1H), 3.77 (s, 3H), 3.64 - 3.10 (m, 3H), 2.94 (s, 3H), 2.47 (s, 3H), 2.17 (s, 3H), 1.14 (t, J = 7.1 Hz, 4H);13C NMR (101 MHZ, CDCh) 8 168.14, 154.43, 151.79, 139.40, 132.71, 128.81, 122.55, 122.00, 51.34, 21.69, 17.43; MS (ESI) m / z calcd for Ci4H2iN2O2+[M+H]+249, found 249.EXAMPLE 8
[0139] Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1)S3a (neutral form) S5-HCIS3a-HCI (HCI salt)
[0140] Preparation 1: To a 40 mL vial with a stir bar was added isopropyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3a-HCI, 1.13 g, 3.62 mmol) and 37% hydrogen chloride aqueous solution (1.86 g, 4.25 mL, 12.0 molar, 51.0 mmol). The vial was capped, the reaction mixture was stirred at 600 rpm and was heated to 65 °C for 2 h. After 2 h, the solution was placed under vacuum to remove isopropanol (15 kPa (150 mbar) and a temperature of 60-65 °C). The solution was then heated at 65 °C for an additional 18 h. Upon analysis by HPLC that showed >95% conversion, the mixture was concentrated under vacuum. The mixture was cooled to 0 °C, and THF (4.18 g) was slowly added dropwise at 0 °C. The mixture was stirred for 2 h at 0 °C, and the solids were collected by filtration to afford the title compound after drying as an off-white solid (S5-HC1, 0.77 g, 79% yield). Analytical data matched those above.
[0141] Preparation 2 To a 20 mL vial equipped with a stir bar was added isopropyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3a, 1.0 g, 3.62 mmol) and isopropanol (6.4 mL, 5.0 g). Sodium hydroxide (174 mg, 4.34 mmol) was then added to the solution. The vial was sealed, and the reaction mixture was stirred at 85 °C for 17 h. Upon completion, as confirmed by HPLC, the reaction mixture was allowed to cool to ambient temperature. The resulting reaction mixture was concentrated under a vacuum of 10 kPa (100 mbar) at 50 °C and reduced by approx. 50% volume. The resultant solution was cooled to 0 °C, and a solution of hydrogen chloride in isopropanol (317 mg, 2.17 mL, 4.0 molar, 8.68 mmol) was added dropwise. After the solution was stirred at 0 °C for 45 min, the ice bath was removed, and the solution was stirred an additional 2 h at ambient temperature. The solids were filtered, and the filter cake was rinsed with additional isopropanol (6.91 g) and methyl / c77-butyl ether (5.12 g). The collected solids were dried under vacuum to afford 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 1.16 g, 93% yield) as a white powder. Analytical data matched those above.EXAMPLE 9
[0142] Synthesis of sodium 4-( ( (ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate(S5-Na)S3a S5-Na
[0143] To a 50 mb flask equipped with a stir bar was added isopropyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3a, 1.71 g, 6.07 mmol) and isopropanol (9.8 m , 7.69 g). Sodium hydroxide (291 mg, 7.28 mmol) was added to the solution. The flask was equipped with a condenser, and the reaction mixture was stirred at 80 °C for 17 h. Upon completion, as confirmed by HPLC, the reaction mixture was allowed to cool to ambient temperature. The resulting reaction mixture was concentrated to approximately 73% mass under a vacuum of 10 kPa (100 mbar) at 50 °C. The resultant solution was heated to 50 °C, and then methyl zc / 7-butyl ether (19.5 mb, 14.4 g) was added dropwise in 4 equal portions at time intervals of 10-15 min. The mixture was stirred at 50 °C for 30 min, after which the solution was allowed to cool to ambient temperature and stirred for an additional 2 h. The solids were filtered, and the filter cake was rinsed with additional methyl / c / V-butyl ether (30 mb, 22 g). The collected solids were dried to afford the title compound (S5-Na, 1.55 g, 89% yield) as an off-white powder: ’H NMR (500 MHz, DMSO-< / 6) 8 7.56 (br s, 1H), 7.40 (s, 1H), 6.40 (s, 1H), 3.34 (br s, 2H), 2.91 (br s, 3H), 2.41 (s, 3H), 2.09 (s, 3H), 1.11 (t, J= 7.08 Hz, 3H);13C NMR (126 MHz, DMSO-t / e) 8 173.33, 150.04, 135.24, 134.96, 131.93, 126.32, 120.50, 49.21, 27.31, 25.91, 21.80, 17.91; MS (ESI) m / z calcd for Ci3Hi9N2O2+[M+H]+235; found 235.EXAMPLE 10
[0144] Synthesis of 4-(difluoromethoxy)benzaldehyde (S7)56 S7
[0145] A 2 -liter flask, equipped with a nitrogen gas inlet, overhead stirrer and temperature probe was charged with potassium hydroxide (315 g, 5610 mmol) and water (468 mL).Acetonitrile (468 mL) and 4-hydroxybenzaldehyde (S6, 45.7 g, 374 mmol) were then sequentially added. The mixture was cooled to < 5 °C in an ice / water bath. Diethyl (bromodifluoromethyl)phosphonate (150 g, 561 mmol) was then added dropwise over 30 min. The reaction mixture was stirred in the ice / water bath for 30 min and then the ice bath was removed. The reaction mixture was stirred at ambient temperature for 3 h. The organic layer was collected, and the aqueous layer was extracted with MTBE (250 mL x 2). Organic layers were combined, dried over sodium sulfate, filtered and concentrated to afford the desired product, 4- (difluoromethoxy)benzaldehyde (S7, 60.5 g, 94% yield): 'H NAIR (500 MHz, CDCh) 8 9.94 (s, 1H), 7.88 (d, J= 8.3 Hz, 2H), 7.21 (d, J= 8.3 Hz, 2H), 6.60 (t, J= 72.9 Hz, 1H);13C NMR (126 MHz, CDCh) 8 189.14, 154.15 (t, J = 2.8 Hz), 131.76, 130.14, 117.47, 113.79 (t, J= 210 Hz);19F NMR (471 MHz, CDCh) 8 -82.45; MS (El) calcd for [CsH6F2O2]+[M]+172.0, found 172.0.EXAMPLE 11
[0146] Synthesis of (4-(difhioromethoxy)phenyl)methanol (S8)57 S8
[0147] Preparation 1: A flask equipped with a nitrogen inlet, overhead stirrer and temperature probe was charged with 4-(difluoromethoxy)benzaldehyde (S7, 60 g, 349 mmol), followed by ethanol (611 mL). The mixture was cooled to < 5 °C in an ice / water bath. Sodium borohydride (13.2 g, 349 mmol) was added portion-wise, and the mixture was stirred for 1 h andallowed to warm to ambient temperature. Upon reaction completion, the mixture was quenched by the addition of 2 M HC1 (50 mL), concentrated under vacuum to 25% volume and extracted with ethyl acetate (300 mL x2). The combined organic extract was dried over magnesium sulfate and concentrated under vacuum to afford (4-(difluorom ethoxy )phenyl)methanol (S8, 55.1 g, 316 mmol, 91% yield): 'H NMR (500 MHz, CDCh) 5 7.37 (d, J= 8.4 Hz, 2H), 7.12 (d, J= 8.5 Hz, 2H), 6.50 (t, J = 73.9 Hz, 1H), 4.68 (d, J= 4.4 Hz, 2H), 1.73 (d, J = 5.3 Hz, 1H);13C NMR (126 MHz, CDCh) 8 150.58 (t, J= 2.8 Hz), 138.06, 128.47, 119.72, 115.91 (t, J= 260 Hz), 64.60;19F NMR (471 MHz, CDCh) 8 -80.75; MS (El) calcd for [C8H7F2O2]’ [M-H]’ 173.0, found 173.0.
[0148] Preparation 2: A jacketed reactor equipped with a nitrogen inlet, outlet, overhead stirrer, and temperature probe was charged with ethanol (475 mL) and the jacket temperature was set to 3 °C. The mixture was stirred at 500 rpm. Once the internal temperature was below 5 °C, sodium borohydride (15.1 g, 0.33 equiv, 392 mmol) was added in portions over 2 min. 4- (Difluoromethoxy)benzaldehyde (S7, 215 g, 1.19 mol) was then added slowly over 90 min to keep the temperature below 5 °C. After addition of aldehyde was complete, the reaction was stirred for an additional 30 min and then analyzed by HPLC, showing >99% conversion. The reaction was quenched by slow addition of 2 M HC1 (200 mL) over 1 h. Solids were present, and the mixture was filtered through a fritted funnel and washed with water (50 mL) and DCM (50 mL). The filtrate was concentrated to remove most of the EtOH. The mixture was then diluted with DCM (400 mL) and 10 wt % brine solution (400 mL). The organic layer was collected, dried over sodium sulfate, filtered, and concentrated to afford (4-(difluorom ethoxy )phenyl)methanol (S8, 211 g, 1.18 mol, 98% yield). Analytical data matched those above.
[0149] Preparation 3: A 1 -liter reactor was charged with 4-hydroxybenzaldehyde (S6, 30.0 g, 246 mmol) and isopropyl alcohol (z-PrOH, 220 g) at ambient temperature. The reactor jacket temperature was increased to 50 °C. A parallel addition of NaOH (160 g, 25 wt %, 983 mmol) and Freon-22 (chlorodifluoromethane, 62.5 g, 722 mmol) was conducted over 70 min. During the parallel addition, the internal temperature rose to 55 °C. After the parallel addition was complete, the jacket temperature was reduced to 12 °C. When the internal temperature was below 40 °C, the reaction mass was filtered to remove inorganics. The filtrate was added backinto the reactor. GC-FID analysis showed >95% intermediate 4-(difluoromethoxy)benzaldehyde (S7). When the internal temperature of the above solution was below 15 °C, a solution of sodium borohydride (18.5 mb, 12 wt % aq with 14 M NaOH stabilizer, 81 mmol) was added over 15 min. During the addition, the internal temperature was maintained between 20 - 22 °C. After 30 min post addition, the jacket temperature was increased to 20 °C. Stirring was stopped, and the aqueous phase was separated. An aqueous wash was prepared (120 g water, saturated with 20 g NaCl) and added to the reaction mixture. The mixture was stirred for 5 min, and after stirring was stopped the phases readily settled. The aqueous phase was separated, and the / -PrOH phase was analyzed by GC-FID showing 98% (4-(difluoromethoxy)phenyl)methanol (S8). The organic phase was concentrated under vacuum. After most of the z-PrOH was removed, the vacuum was released, and toluene (150 mL) was added. The mixture was stirred and after 5 min, stirring was stopped and the phases were separated. The organic phase was transferred to a flask, concentrated under vacuum, and subjected to short path distillation. From the distillation, (4- (difluoromethoxy)phenyl)methanol (S8) was isolated (34.7 g, 81% yield over 2 steps) as a faintly orange oil. Analytical data matched those above.
[0150] Preparation 4: A flask equipped with a stir bar, temperature probe, gas inlet, and outlet to a scrubber was charged with 4-hydroxybenzaldehyde (S6, 5.0 g, 1 equiv, 40.9 mmol) and stirred in a mixture of isopropanol (40 mL) and water (10 mL). The solution was then heated to 60 °C and held for 30 min. A solution of 50 wt % aqueous sodium hydroxide (13.1 g, 4 equiv, 164 mmol) was added to the solution over 15 min, while maintaining the internal temperature <65 °C. After complete addition, chlorodifluoromethane (also known as Freon-22, 7.1 g, 2 equiv, 81.9 mmol) was bubbled through the reaction over 20 min. After 1 hour, complete consumption of 4-hydroxybenzaldehyde was observed by HPLC, and the reaction mixture was cooled to 25 °C. The reaction mixture was concentrated under vacuum to remove most of the solvent. The resulting mixture was diluted with ethanol (40 mL) and 35 wt % aqueous formaldehyde (17.6 g, equiv, 205 mmol) was added to the reaction slowly. While stirring in an ambient water bath, sodium hydroxide (16.4 g, 50 wt %, 5 equiv, 205 mmol) was added to the reaction dropwise over 20 min while maintaining the internal reaction temperature below 30 °C. The reaction was then stirred at 25 °C for 2 h. The reaction mixture was diluted with water (50 mL) and extracted withMTBE (80 mL). The combined organic layer was washed with 1 N HC1 solution (50 mL), followed by saturated sodium chloride solution (50 mL). The resulting organic layer was dried over sodium sulfate, filtered, and concentrated under vacuum to obtain 4- (difluoromethoxy)phenyl)methanol (S8) as a thick orange oil (77% yield over 2 steps). Analytical data matched those above.EXAMPLE 12
[0151] Synthesis of l-(chloromethyl)-4-(difluoromethoxy)benzene (S9)S8 S9
[0152] Preparation 1: A flask equipped with nitrogen inlet, stir bar and temperature probe was charged with (4-(difluoromethoxy)phenyl)methanol (S8, 1.74 g, 10 mmol) and DCM (13.6 mL). The mixture was stirred and cooled to < 5 °C in an ice / water bath. Triethylamine (1.46 mL, 10.5 mmol) was then added. Thionyl chloride (0.95 mL, 13.0 mmol) was then added slowly over 1 h via syringe pump to keep the internal temperature < 5 °C. After 1 h, the reaction was quenched by addition of aqueous HC1 (I M, 10 mL). The organic layer was collected and washed with aqueous potassium carbonate (5 wt %, 10 mL). The organic layer was then dried over sodium sulfate, fdtered, and concentrated to afford the desired product, l-(chloromethyl)-4- (difluoromethoxy)benzene (S9, 1.74 g, 8.96 mmol, 90% yield):rH NMR (500 MHz, CDCL) 5 7.42 - 7.36 (m, 2H), 7.14 - 7.08 (m, 2H), 6.51 (t, J= 1 .1 Hz,lH), 4.57 (s, 2H).19F NMR (471 MHz, CDCL) 8 -80.99.13C NMR (126 MHz, CDCL) 8 151.07 (t, J= 3.0 Hz), 134.70, 130.18, 119.77, 115.76 (t, J= 260 Hz), 45.38. MS (El) cal cd for [CSH7F2OC1]+[M]+192.0, found 192.0.
[0153] Preparation 2: A 1-L reactor was charged with 4-hydroxybenzaldehyde (S6, 30.0 g, 246 mmol) and z-PrOH (197 g). The reactor jacket temperature was increased to 50 °C. A parallel addition of NaOH (157 g, 25 wt % aq, 983 mmol, 4 equiv) and Freon-22 (64 g, 737 mmol, 3 equiv) was conducted over 75 min. After the parallel addition was complete, the jacket temperature was reduced to 12 °C. When the internal temperature was below 40 °C, the reaction mass was filtered to remove inorganics. The filtrate was added back into the reactor. After thelayers settled, GC-FID analysis indicated 94% conversion. When the internal temperature was below 15 °C, a solution of sodium borohydride (18.5 mL, 12 wt % aq with 14 M NaOH stabilizer, 81 mmol, 0.33 equiv) was added over 15 min. During the addition, the internal temperature was maintained between 20 - 22 °C. After 30 min post addition, the jacket temperature was increased to 20 °C. Stirring was stopped, and the aqueous phase was separated. An aqueous wash was prepared (150 g water, 12 mL concentrated HC1, saturated with 50 g NaCl). The acidic aqueous phase was added, resulting in minimal hydrogen evolution and a noticeable color change. The mixture was stirred for 5 min, and after stirring was stopped the phases readily settled. The aqueous phase was separated and the z-PrOH phase was analyzed by GC-FID showing 98% S8. The jacket temperature was increased to 60 °C and z-PrOH was removed under vacuum (9.33 kPa (70 torr)). After most of the z-PrOH was removed, the vacuum was released, and toluene (111 g) was added. The mixture was stirred and after 5 min, stirring was stopped and the phases were separated. The organic phase was further distilled (140 g of distillate removed). After the distillation, the jacket temperature was set to 12 °C and DCM (300 mL) was added. GC-FID analysis of the DCM solution showed 93% (4- (difluoromethoxy)phenyl)methanol (S8). When the internal temperature was below 15 °C, thionyl chloride (24 mL, 332 mmol, 1.35 equiv) was added over 20 min. After 18 h, water (120 g) was added. After 5 min, stirring was stopped and the phases were separated. A rinse solution was prepared (200 g water, 21 g of 50 wt % NaOH) and added to the mixture. After 5 min, stirring was stopped and the phases were separated. The DCM was removed by vacuum distillation and GC-FID analysis indicated 76% conversion. The residue was transferred to a round-bottom flask for short path distillation. From the distillation, l-(chloromethyl)-4- (difluoromethoxy)benzene was isolated (S9, 34 g, 72% yield over 3 steps). Analytical data matched those above.EXAMPLE 13
[0154] Synthesis of 4-(difluoromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)- 2,5-dimethylbenzoate (SI)
[0155] Preparation 1 A flask fitted with a stir bar was charged with 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 1.35 g, 5 mmol), anhydrous potassium carbonate (1.52 g, 11 mmol), benzyltriethylammonium chloride (57 mg, 0.25 mmol), and anhydrous ethyl acetate (10 mL). The reaction mixture was stirred at ambient temperature for 30 min before adding l-(chloromethyl)-4- (difluoromethoxy)benzene (S9, 1.06 g, 5.5 mmol). The reaction mixture was heated to 50 °C and stirred for 18-20 h. After complete conversion was observed, the mixture was diluted with water (10 mL) and was transferred to a separatory funnel. The mixture was extracted with ethyl acetate (10 mL), and the organic layer was washed with brine (10 wt %, 10 mL). The solution was concentrated under vacuum to afford the title compound (SI, 1.8 g, 92% yield):!H NMR (400 MHz, CDCh) 8 7.78 (s, 1H), 7.55 - 7.32 (m, 3H), 7.13 (d, J= 8.6 Hz, 2H), 6.75 - 6.23 (m, 2H), 5.28 (s, 2H), 3.62 - 3.23 (m, 2H), 3.01 (s, 3H), 2.54 (s, 3H), 2.23 (s, 3H), 1.22 (t, J= 7.1 Hz, 3H);13C NMR (126 MHz, CDCh) 5 167.29, 154.83, 151.82, 150.93, 150.90, 150.88, 139.70, 133.99, 132.77, 129.76, 128.92, 122.11, 121.99, 119.56, 117.98, 115.92, 113.86, 65.16, 21.87, 17.46;19F NMR (376 MHz, CDCh) 5 -80.75;. MS (ESI) m / z calcd for C2IH25F2N2O3+[M+H]+391 , found 391.
[0156] Preparation 2, Step A: Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5- dimethylbenzoyl chloride hydrochloride (S5b-HCl)
[0157] A 100 mL three-neck round-bottom flask equipped with a condenser was charged with 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 1.35 g, 5.0 mmol) and DCM (10 mL) under nitrogen. Thionyl chloride (0.4 mL, 5.5 mmol) was added dropwise over 1 min. The reaction mixture was heated to 40 °C and was stirred for 3 h. Formation of the acid chloride hydrochloride (S5b-HCl) was detected as measured by UPLC with an alcohol quench.
[0158] Alternatively, S5b-HCl may also be isolated as follows. The reaction mixture was cooled to room temperature and concentrated to remove DCM, yielding a yellow solid (1.41 g, 97% yield): ’H NMR (500 MHz, CDC13, mixture of rotamers) 8 12.35 (d, J= 13.0 Hz, 1H), 12.29 (d, J= 12.8 Hz, 2.3H), 8.47 (d, J= 11.8 Hz, 2.3H), 8.39 (d, J= 12.0 Hz, 1H), 7.95 (s, 3.3H), 7.42 (s, 2.3H), 7.37 (s, 1H), 4.02 (q, J= 7.2 Hz, 2H), 3.76 (q, J= 7.2 Hz, 4.6H), 3.51 (s, 6.9H), 3.42 (s, 3H), 2.50 - 2.46 (m, 9.9H), 2.39 (s, 9.9H), 1.35 - 1.28 (m, 9.9H);13C NMR (126 MHz, CDCI3, mixture of rotamers) 8 166.68, 166.66, 154.54, 154.39, 140.84, 140.77, 140.56, 140.53, 136.82, 136.76, 131.19, 131.16, 131.00, 130.77, 127.51, 127.34, 52.47, 46.62, 41.68, 37.07, 21.30, 21.28, 18.38, 13.58, 11.40. MS (ESI) calculated for C13H18CIN2CF [M-C1]+253.1102, found 253.1107.
[0159] Preparation 2, Step B: 4-(difluoromethoxy)benzyl-4-( ((ethyl(methyl)amino)methylene)amino)-2, 5-dimethylbenzoate (SI )
[0160] To the reaction mixture from Step A above was added (4- (difluoromethoxy)phenyl)methanol (S8, 0.75 mL, 5.5 mmol) over 1 min. The reaction mixture was stirred at 40 °C overnight. The mixture was concentrated under reduced pressure, ethyl acetate (30 mL) and water (30 mL) were added, and the mixture was transferred to a separatory funnel. The organic layer was removed, and the aqueous layer was washed twice with ethyl acetate (30 mL x 2). The aqueous layer was transferred to a round-bottom flask and neutralized with 2 N NaOH solution (10 mL). The mixture was transferred to a separatory funnel and extracted with ethyl acetate (30 mL). The organic layer was washed with saturated brine (10 mL), dried with sodium sulfate, and concentrated by rotary evaporation to provide 4- (difluoromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)-2, 5-dimethylbenzoate (SI, 1.61 g, 73% yield) as a yellow oil. Analytical data matched those above.EXAMPLE 14
[0161] Synthesis of 4-(difluoromethoxy)benzyl-4-( ((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI)S1
[0162] Preparation 1: A 50 mL flask equipped with a stir bar, reflux condenser, and septum was charged with methyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3j, 0.32 g, 1.3 mmol), (4-(difluoromethoxy)phenyl)methanol (S8, 270 mg, 1.55 mmol), and dibutyltin oxide (32 mg, 0.13 mmol). The flask was evacuated and backfilled with nitrogen 3 times, and xylenes (2.6 mL) was added to this mixture. The reaction mixture was stirred at 130 °C for 24 h. The reaction mixture was cooled, diluted with EtOAc (50 mL), and washed with water (2 x 50 mL). The organic layer was separated, dried over sodium sulfate, and concentrated under vacuum to afford SI (482 mg, 95% yield) as a pale-yellow oil. Analytical data matched those above.
[0163] Preparation 2: Representative procedure for base-catalyzed transesterification
[0164] A flask equipped with a stir bar and reflux condenser was charged with methyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3j, 2.00 g, 8.05 mmol), (4- (difluoromethoxy)phenyl)methanol (S8, 1.75 g, 10.1 mmol) and xylenes (27.2 mL). The contents of the reaction were heated to 80 °C, and NaOH (2 N, 0.40 mL, 0.81 mmol) was added. The reaction mixture was stirred at 80 °C with nitrogen purging. After 24 h, the reaction mixture was diluted with EtOAc (100 mL) and washed with water (50 mL). The aqueous layer was extractedwith EtOAc (2 x 50 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under vacuum. The resulting material was purified by column chromatography to afford SI (2.65 g, 84% yield) as a colorless oil. Analytical data matched those above.EXAMPLE 15
[0165] Preparing the 4-(difluoromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)-2, 5 -dimethylbenzoate (neutral form of ) from 4-(difhioromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S1-HC1)S1
[0166] Preparation 1, Step A: To a solution of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S1-HC1, 100 g, 234 mmol) in ethyl acetate (800 mL) at ambient temperature was slowly added a solution of water (800 mL) containing sodium hydroxide (11.2 g, 281 mmol), with continued mixing. After vigorous mixing, the phases were allowed to settle, and the organic layer was collected and washed with an aqueous solution of saturated sodium bicarbonate (100 mL). The organic layer was collected, dried over sodium sulfate, filtered through a pad of Celite®, and concentrated to give the title compound (SI, 89 g) as an amber honey-like oil.XH NMR (400 MHz, CDCh) 8 7.78 (s, 1H), 7.55 - 7.32 (m, 3H), 7.13 (d, ,7 = 8.6 Hz, 2H), 6.75 - 6.23 (m, 2H), 5.28 (s, 2H), 3.62 - 3.23 (m, 2H), 3.01 (s, 3H), 2.54 (s, 3H), 2.23 (s, 3H), 1.22 (t, J= 7.1 Hz, 3H).13C NMR (126 MHz, CDCh) 8 167.29, 154.83, 151.82, 150.93, 150.90, 150.88, 139.70, 133.99, 132.77,129.76, 128.92, 122.11, 121.99, 119.56, 117.98, 115.92, 113.86, 65.16, 21.87, 17.46.19F NMR (376 MHz, CDC13) 6 -80.75. MS (ESI) m / z calcd for C2iH25F2N2O3+[M+H]+391, found 391.
[0167] Preparation 1, Step B: Preparing crystalline SI
[0168] To SI (158 g, 404.7 mmol) oil, containing a trace amount of EtOAc (2.6 mL), at ambient temperature, was added methyl Zc / 7-butyl ether (72 mL) and / / -heptane (77.5 mL). The solution was warmed to 30 °C. After 1 h of mixing, the solution was cooled to 0 °C over 60 min. After nucleation was observed, / / -heptane (615 mL) at ambient temperature was added to the slurry over 5 h. If no nucleation was observed, 2.5 wt % of SI seeds with respect to initial SI can be added. After / / -heptane addition, the slurry was held at 0 °C for 2 h before being filtered and washed with cold H-heptane (300 mL). The resulting wet cake was dried under vacuum at ambient temperature to yield SI (145 g, 92% yield) as an off-white solid. Analytical data matched those above.
[0169] Preparation 2: 1 g of 4-(Difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI) as a colorless oil in ethyl acetate. The solution was concentrated under vacuum with stirring at 35 °C for 5 h. The oil crystallized to an off-white solid upon cooling to room temperature.
[0170] Acid / Base extraction for purification of \
[0171] To a stirred solution of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI, 1.50 g, 3.84 mmol) in EtOAc (12 mL) was added HC1 in EtOAc (1 M, 4.6 mL, 4.61 mmol). The mixture was stirred for 15 min at ambient temperature, and the solution turned from clear yellow to opaque white. Water (12 mL) was added, and mixing was continued for 30 min. The mixture was transferred to a separatory funnel, and the layers were separated. The aqueous layer was transferred to a flask before adding potassium carbonate (0.64 g, 4.61 mmol) and EtOAc (12 mL). The mixture was stirred at ambient temperature for 1 h before transferring to a separatory funnel. The layers were separated, and the organic layer was concentrated under vacuum and then was dried under vacuum at 35 °C to provide SI (1.39 g, 93% yield) as a white solid. Analytical data matched those above.EXAMPLE 16
[0172] Preparation of crystalline S1-HC1 from SIS1-HCI
[0173] Preparation 1: To a solution of (4-difluromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)-amino)-2,5-dimethylbenzoate (SI, 200 g, 0.51 mol) in ethyl acetate (400 mb) at ambient temperature in a glass-lined reactor, water (4 mL) was added at ambient temperature. The reaction mixture was cooled to < 5 °C. A solution of HC1 in ethyl acetate (138 mL, 4 M, 0.51 mol) was added to the mixture at < 5°C over 4-5 h to adjust the pH (2.5 to 3.5). The reaction mass was stirred for 30 min at < 5 °C before gradually allowing the reaction mixture to warm to ambient temperature. The reaction mixture was stirred for 16-18 h at ambient temperature. The reaction mixture was then cooled to < 5 °C and stirred for 2 h. The solids were filtered, and the slurry was washed with pre-cooled ethyl acetate (200 mL). The wet cake was allowed to set for 30 min on vacuum to dry. Afterwards, the solid was dried at 50-55 °C under vacuum for 2-3 h to afford the title compound (S1-HC1, 187.4 g, 86% yield) as an off- white solid. ’HNMR (400 MHz, DMSO4 mixture of rotamers) 8 11.18 - 10.79 (m, 1H), 8.54 - 8.27 (m, 1H), 7.79 (s, 1H), 7.55 (d, J= 8.2 Hz, 2H), 7.38 - 7.33 (m, 1H), 7.26 (t, J= 74.1 Hz, 1H), 7.22 (d, J= 8.2 Hz, 2H), 5.32 (s, 2H), 3.75 - 3.61 (m, 2H), 3.32 - 3.25 (m, 3H), 2.52 - 2.49 (m, 3H), 2.38 - 2.32 (m, 3H), 1.30 - 1.23 (m, 3H);19F NMR (376 MHz, DMSO-tfc) 8 -82.14; mp95- 100 °C.
[0174] Preparation 2: A reactor equipped with overhead agitator, temperature probe, and nitrogen inlet was charged with crude 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI, 10 g, 26 mmol), ethyl acetate (28 mb) and HC1 (1 M in ethyl acetate, 31.2 mmol, 31.2 mb). The reaction mixture was stirred at 20 °C before seeds of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S1-HC1, 0.11 g) were added after solids had begun to form. The mixture continued to stir for 19 h. The mixture was vacuum filtered and the solids were dried in a vacuum oven to afford 4- (difluoromethoxy)benzyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (SI, 6.09 g, 45% yield). Analytical data matched those above.EXAMPLE 17
[0175] Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1)S3a-HCI S5-HCI
[0176] To a 40-mL vial equipped with a stir bar was added isopropyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3a-HCl, 1.5 g, 1.0 equiv, 4.8 mmol) and aqueous 6 M HC1 (6.0 mb, 4.5 wt equiv, 7.5 equiv). The vial was capped, and the reaction mixture was stirred (600 rpm) at 65 °C for 18 h. Upon completion, as confirmed by HPLC, the reaction mixture was cooled to 0 °C in an ice bath. The solids were filtered, and the filter cake was rinsed with acetone (14.8 mb, 11.6 g, 7.7 wt equiv). The collected solids were dried to afford 4-(((ethyl(methyl)amino)methylene)amino)-2,5- dimethylbenzoic acid hydrochloride (S5-HC1, 1.1 , 4.2 mmol, 87% yield, 99 wt % purity) as a white powder. Analytical data matched those above.EXAMPLE 18
[0177] Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1)S3a-HCI S5-HCI
[0178] To a 1-L jacketed reactor equipped with a vacuum distillation system, a solution of isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3a- HC1, 409 g total, 9.3 wt % S3a-HCl, 38.0 g S3a-HCl, 121 mmol, 1.0 equiv) and aqueous 6 M HC1 (140 g, 3.7 wt equiv, 6.3 equiv HC1) were added at 25 °C. The mixture was stirred at 300 rpm. The jacket temperature was adjusted to 40 °C for 20 min and then 60 °C for 30 min. As the temperature increased, the organic solvent was distilled off under atmospheric pressure. Once most of the dichloromethane was removed, the jacket temperature was increased to 110 °C. When the internal temperature stabilized at 100 °C, most of the organic fractions were distilled (330 g). The reaction mixture was stirred at this temperature for 18 hours, until S3a-HCl was less than 1.0 area percent (A%) by HPLC. Upon completion, as confirmed by HPLC, 1% NaCl (1.3 g, 23 mmol) was added to the reaction mixture. The slurry was cooled to 0 °C over 1 hour and held for 3 hours. The solids were filtered, and the filter cake was rinsed with acetone (154 mL, 121 g, 3.2 wt equiv). The collected solids were dried to afford 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 26.7 g, 97.9 mmol, 81% yield, 99 wt % purity) as a white powder. Analytical data matched those above.EXAMPLE 19
[0179] Synthesis of 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1)
[0180] Step A In a 1-L reactor equipped with a mechanical stirrer, nitrogen inlet, reflux condenser, and a vent line attached to a base scrubber, were added Af-ethyl-A-methyl formamide (S13, 38.4 g, 440 mmol, 1.1 equiv) and DCM (200 mL). To this solution was added oxalyl dichloride (53.9 g, 36.4 mL, 420 mmol, 1.05 equiv) at 22-24 °C over 30 min using a syringe pump. The stirring continued for an additional 30 min. 2,5-Dimethylaniline (S4, 50.0 g, 97 wt %, 400 mmol, 1 equiv) was added to this solution dropwise over 90 min while maintaining the temperature of the reaction below 22-24 °C. After the addition was complete, the stirring was continued for an additional 1 h. The resultant solution (A"-(2,5-dimethylphenyl)-A-ethyl-A- methylformimidamide hydrochloride; S2-HC1) was carried forward to the next step without any further purification or operations.
[0181] Step Bl: In a 1-L jacketed reactor equipped with temperature probe, condenser attached to a base scrubber, nitrogen inlet, and a liquid addition dip tube, was added aluminum trichloride (82.7 g, 99 wt %, 614 mmol, 3 equiv) under nitrogen. The reactor was evacuated and backfilled with nitrogen (3 times), and DCM (175 mL) was added. Oxalyl dichloride (53.0 g, 35.8 mL, 98 wt %, 409 mmol, 2.0 equiv) was added dropwise at 0 °C to this mixture over 45 min using a syringe pump, keeping the internal temperature between 1-2 °C. The reaction mixture was stirred at 0 °C for 30 min. 7V-(2,5-Dimethylphenyl)-A-ethyl-A-methylformimidamide hydrochloride (S2-HC1, 182 g, 25.5 wt %, 205 mmol, 1 equiv) from the previous step was added dropwise over 3 hours at 0 °C to this mixture. The reaction mixture was stirred at 0 °C for 14 h and carried forward to the next step without any further purification or operations.
[0182] Step B2: In a 1-L jacketed reactor equipped with a temperature probe, dry-ice condenser attached to a base scrubber and a receiver flask, nitrogen inlet, and a liquid addition dip tube, was added water (379 g, 0.4 L, 1.0 mol, 103 equiv). The reactor was heated to 40 °C. The reaction mixture from Step Bl was added to this mixture using a pump feed using a dip tubeover 45 min. After an additional 6 h, the reactor was cooled to 0 °C and the mixture was stirred for 12 h. The slurry obtained was filtered through a glass fritted funnel. The wet cake was washed with cold 2 N HC1 (50 mb x 2). The wet cake was suction dried and was washed with methyl isobutyl ketone (MIBK, 100 mb xl). The material was dried in a vacuum oven at 50 °C for 24 h to afford 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 50.3 g, 186 mmol, 90.8%). Analytical data matched that above.EXAMPLE 20
[0183] Synthesis of 4-(((ethyl(methyl)ammo)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1)S3a S5-HCI
[0184] To a 20-mL vial equipped with a stir bar were added isopropyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3a, 1.0 g, 3.6 mmol, 1.0 equiv) and isopropanol (6.4 mL, 5.0 g, 5.0 wt equiv). Sodium hydroxide (179 mg, 4.4 mmol, 1.2 equiv) was added to the solution. The vial was sealed, and the reaction mixture was stirred at 85 °C for 19 h. Upon completion, as confirmed by HPLC, the reaction mixture was cooled to 0 °C and a solution of hydrogen chloride in isopropanol (319 mg, 2.2 mL, 4 M, 8.7 mmol, 2.4 equiv) was added dropwise. After the solution was stirred at 0 °C for 40 min, the ice bath was removed, and the solution was stirred an additional 1.5 h at ambient temperature. The solids were filtered, and the filter cake was rinsed with additional isopropanol (3.6 g, 3.6 wt equiv) followed by deionized water (2.6 g, 2.6 wt. equiv). The collected solids were dried under reduced pressure to afford 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (also known as 4-carboxy-A-((ethyl(methyl)amino)methylene)-2,5-dimethylbenzenaminium chloride, S5-HC1, 748 mg, 2.8 mmol, 75% yield, 96 wt % purity) as a white powder. Analytical data matched those above.EXAMPLE 21
[0185] General Procedure for Synthesis of (4-(difluoromethoxy)phenyl)methanol (S8)S6 S8
[0186] A 1-L reactor was charged with 4-hydroxybenzaldehyde (S6, 30.0 g, 246 mmol) and isopropanol (220 g, 280 mL, 9.3 vol). The jacket temperature was increased to 50 °C. A parallel addition of NaOH solution (40 wt %, 3-4 equiv) and Freon-22 (4 - 6 equiv) was conducted for the specified time. During the parallel addition, the internal temperature maintained at < 56 °C. After the parallel addition was complete, the jacket temperature was reduced to 10 °C. When the internal temperature was below 40 °C, the reaction mass was filtered to remove inorganics. The filtrate was re-added to the reactor. After the layers settled, the bottom aqueous phase was removed. HPLC analysis of both the aqueous and organic layers showed excellent partition of 4- (difluoromethoxy)benzaldehyde (S7, not shown) into the organic isopropanol layer. When the internal temperature was below 15 °C, a solution of sodium borohydride (NaBFh, 12 wt % aq with 40 wt % NaOH stabilizer, approx. 0.3 equiv NaBH4, 1 equiv NaOH) was added over 25 min. During the addition, the internal temperature was maintained between 20-25 °C. After addition, the jacket temperature was increased to 25 °C, and the reaction mixture was stirred for an additional 2 h prior to quench and specified workup procedure that affords of (4- (difluoromethoxy)phenyl)methanol (S8) as an oil that was taken directly into the next step without further purification. Analytical data matched those above.
[0187] Isolation of (4-(difluoromethoxy)phenyl)methanol (S8) via acid-base wash
[0188] The general procedure for synthesis of 4-(difluoromethoxy)benzaldehyde (S7) using NaOH (98 g, 40 wt %, 983 mmol, 4 equiv) and Freon-22 (117 g, 1355 mmol, 5.5 equiv) was conducted over 7 h. Reduction to S8 was carried out using a solution of NaBH4 (12 wt % aq with 40 wt % NaOH stabilizer, 25.1 g, 18.3 mL, 79.7 mmol, 0.32 equiv NaBH4), and the reaction mixture was stirred at 10 °C for 18 h. The internal temperature was increased to 25 °C, and the mixture was stirred for 2 h. Upon reaction completion, 2 N HC1 (120 mL, 4 vol) was slowly charged to the reactor in 10 mL portions over 10 min. Gas generation and an exotherm wereobserved; the internal temperature reached 30 °C. After addition, the layers were allowed to settle, and the bottom aqueous layer was removed. Isopropanol was removed from the organic layer under vacuum (9.33 kPa (70 torr), 45 °C) to afford a heterogeneous slurry of unpurified S8 DCM (120 mL, 4 vol) was charged to the reactor followed by 1 M NaOH (120 mL, 4 vol). The solutions were stirred for 5 min and allowed to settle. After the layers were separated, the remaining organic layer was washed with 15% brine (60 mL, 2 vol). The organic solvents were removed under vacuum. A light-yellow oil of (4-(difluoromethoxy)phenyl)methanol (S8) was obtained in 72% yield and 95 wt % purity. Analytical data matched those above.EXAMPLE 22
[0189] Preparation of -(chloromethyl)-4-(difluoromethoxy)benzene (S9)S21 S9
[0190] A 2-dram vial was charged with l-difluoromethoxy-4-methylbenzene (S21, 0.20 mL), tri chloroisocyanuric acid (48.5 mg, 0.21 mmol, 0.33 equiv), azobisisobutyronitrile (AIBN, 10.4 mg, 0.063 mmol, 0.1 equiv) and chlorobenzene (0.80 mL). The vial was heated to 65 °C and the mixture was stirred overnight. An aliquot of the reaction was sampled for GC analysis to determine yield and conversion. The reaction mixture was washed with 10% aqueous sodium thiosulfate and concentrated in vacuo. The resulting product was purified via flash column chromatography using hexanes and DCM as the eluent. 67% GC yield was observed, with 55% isolated yield. Analytical data matched those above.EXAMPLE 23
[0191] Synthesis of l-(chloromethyl)-4-(difluoromethoxy)benzene (S9)S8 S9
[0192] A 250-mL round-bottom flask was charged with thionyl chloride (SOCb, 3.6 mL, 49 mmol, 1.3 equiv) and dichloromethane (28 g, 21 mL, 3 vol). The flask was placed in an ice bath to maintain internal temperature ~0 °C. A solution of (4-(difluoromethoxy)phenyl)methanol (S8, 7.0 g, 94 wt %, 37.8 mmol, 1.0 equiv) in DCM (11 g, 8 mL, 1.1 vol) was added over 1 h. After addition, the solution was warmed to ambient temperature, and the reaction mixture was stirred for an additional 2 h. Water (28 mL, 4 vol) was slowly added to the reaction mass. After 30 min, stirring was stopped and the phases were separated (aqueous pH < 2). A rinse solution of 10% sodium bicarbonate (28 mL, 4 vol) was prepared and added to the organic layer. After 5 min, stirring was stopped, and the phases were separated (aqueous pH 7-8). The di chloromethane was washed with a 25% brine solution (28 mL, 4 vol). After the aqueous phase was removed, di chloromethane was removed by vacuum distillation to afford l-(chloromethyl)-4- (difluorom ethoxy )benzene (S9, 92% yield, 95 wt % purity) as a brown oil. Analytical data matched those above.EXAMPLE 24
[0193] Synthesis of 4-(dif!uoromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI)S1
[0194] A 500-mL jacketed reactor equipped with a temperature probe, nitrogen inlet, mechanical stirrer, and a water-cooled condenser was charged with 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 99 wt %, 13.5 g, 50 mmol, 1 equiv) and DCM (100 mL). Thionyl chloride (3.81 mL, 52.5 mmol, 1.05 equiv) was added at room temperature via syringe over 2 min with stirring. The reaction mixture was heated to 40 °C and stirred at reflux for 4 h. To the reaction mixture was added (4- (difluoromethoxy)phenyl)methanol (S8, 98 wt %, 9.85 g, 55.0 mmol, 1.1 equiv) via a syringe over 2 min. The mixture was stirred at reflux at 40 °C overnight. The reaction mixture was cooled to room temperature before addition of a potassium carbonate solution (13 wt % aq, 70 mL, 75 mmol, 1.5 equiv) over 5 min. After stirring for 5 min, the layers were separated, and the DCM layer was collected. The DCM layer was concentrated to afford unpurified 4- (difluorom ethoxy )benzyl-4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate as a dark brown oil (SI, 21.3 g, 88% yield). Alternatively, an acid-base extraction according to that described in Example 15, Preparation 2 was conducted and resulted in a similar yield. Analytical data matched those above.EXAMPLE 25
[0195] Synthesis of 4-(dif!uoromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI)
[0196] A 1-L Optimax 1001 reactor equipped with a temperature probe, nitrogen inlet, and mechanical stirrer was charged with 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoic acid hydrochloride (S5-HC1, 98 wt %, 35 g, 127 mmol, 1 equiv), anhydrous potassium carbonate (38.5 g, 279 mmol, 2.2 equiv), benzyltriethylammonium chloride (BTEAC, 2.88 g, 12.66 mmol, 0.1 equiv), water (1.71 g, 95.0 mmol, 0.75 equiv) and anhydrous ethyl acetate (253 mb, 7.2 vol). The reaction mixture was stirred at room temperature for 30 min before adding l-(chloromethyl)-4-(difluoromethoxy)benzene (S9, 98 wt %, 24.9 g, 127 mmol, 1 equiv). The reaction mixture was stirred overnight at 55 °C. After complete consumption of S5- HC1 was observed by UPLC, water (125 mb, 3.6 vol) was added, and the mixture was stirred for 10 min as it cooled to room temperature. The aqueous layer was removed before washing the organic layer with 1% potassium carbonate solution (125 mb, 3.6 vol). The organic layer was concentrated down to give the desired product, 4-(difluoromethoxy)benzyl-4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate as an oil (SI, 51 g, 91 wt % with remaining EtOAc, 95% yield). Analytical data matched those above.EXAMPLE 26
[0197] Synthesis of isopropyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5- dimethylbenzoate hydrochloride (S3a-HCl)
[0198] Step A An inert glass lined reactor equipped with an overhead agitator, base scrubber, temperature probe, and nitrogen inlet was added A-ethyl-A-methylformamide (15.98 g, 99 wt %, 1.10 equiv, 181.5 mmol) and DCM (80.0 mL). To this solution was added oxalyl dichloride (22.22 g, 15.0 mL, 99 wt %, 1.05 equiv, 173.3 mmol) at 22-24 °C over 30 min using a syringe pump. After the addition was complete, the syringe lines were washed with DCM to ensure complete addition of oxalyl dichloride in the reactor. The stirring was continued for an additional 30 min. 2,5-Dimethylaniline (S4, 20.00 g, 20.6 mL, 1 equiv, 165.0 mmol) was added to this solution dropwise over 90 min while maintaining the temp of the reaction below 22-24°C. After the addition was complete, the stirring was continued for an additional 1 h. The resultant solution (A"-(2,5-dimethylphenyl)-A-ethyl-A-methylformimidamide hydrochloride; S2- HC1) was carried forward to the next step without any further purification or operations.
[0199] Step Bl . An inert glass-lined 1-L reactor equipped with an overhead agitator, base scrubber, temperature probe, syringe line tube, and nitrogen inlet was charged with aluminum trichloride (68.49 g, 98 wt %, 3.05 equiv, 503.4 mmol) and DCM (110.0 mb) under positive pressure of nitrogen and the reactor was cooled to 0 °C. To this stirred solution was added oxalyl dichloride (43.38 g, 29.3 mL, 99 wt %, 2.05 equiv, 338.3 mmol) over 1 h using a syringe pump at 0 °C. The contents of the flask were stirred at 0 °C for an additional 30 min. The DCM solution prepared in the Step A was added dropwise over 3 h at 0 °C to this mixture using a syringe pump. After the addition was complete, the contents were stirred for an additional 1 h and carried forward to the next step without any further purification or operations.
[0200] Step B2 In a 1-L round-bottom flask equipped with a septum, temperature probe, an addition funnel and a reflux condenser with a tube line from reflux condenser to base scrubber was added propan-2-ol (128.9 g, 164 mL, 13 equiv, 2.146 mol). The flask was evacuated and backfilled with nitrogen. A solution of acid chloride prepared in Step Bl was added dropwise using a peristaltic pump at 30 °C. The temperature was maintained below 30 °C during the addition. After the addition was complete, the contents of the flask were stirred at room temperature for 12 h. The reaction mixture was cooled to 0 °C and 2 N HC1 (150 mL) was added dropwise with the aid of addition funnel to this mixture (CAUTION: HC1 evolution). The contents of the flask were stirred at 0 °C for 30 min and at room temperature for 1 h. The contents were transferred to a separatory funnel, and the phases were allowed to separate. The bottom aqueous layer (300.95 g) and the top organic layer (549.5 g) were separated. The organic layer was used directly in the next step without any further purification.EXAMPLE 27
[0201] Synthesis of 4-(difluoromethoxy)benzyl-4-(((ethyl(methyl)amino)methylene)amino)- 2,5-dimethylbenzoate (SI)S1
[0202] Representative example of base-mediated transesterification of ester HCl-salt (S3 salt)
[0203] To a 100-mL two-neck round-bottom flask, equipped with a stir bar and a reflux condenser with an attached Dean-Stark trap, was added methyl 4-(((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S3J-HC1, 1.00 g, 1 equiv, 3.51 mmol) in xylenes (12 mL) under nitrogen. The reaction mixture was stirred at room temperature for 5 min, and sodium methoxide (759 mg, 0.78 mL, 30 wt %, 1.2 equiv, 4.21 mmol) was added. The reaction mixture was stirred for 5 min, and (4- (difluoromethoxy)phenyl)methanol (S8, 795 mg, 1.3 equiv, 4.56 mmol) was added to this mixture. The combined reaction mixture was stirred at 65 °C for 3 h under nitrogen. The reaction showed 90% area under the curve (AUC) for SI after 3 h.
[0204] Using the general procedure above, SI was also generated (72% AUC) using the ethyl ester hydrochloride (S3a-HCl).
[0205] Using the general procedure above, SI was also generated (59% AUC) using the isopropyl ester hydrochloride (S3a-HCI).
[0206] Consequently, in light of the above, the following additional non-exhaustive details (D) are provided.ID. A compound, N ’-(2,5-dimethylphenyl)-A-ethyl-A-methylformimidamide (S2), having the following formulaan acceptable salt thereof.2D. A compound according to ID, wherein the acceptable salt is the hydrochloride salt, having the following formulaS2-HCI3D. A compound (S3), wherein Ri is C3-C8 alkyl, having the following formula,S3, or an acceptable salt thereof.4D. The compound according to 3D, wherein the compound is isopropyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (S3a), having the following formulaS3a5D. The compound according to 3D, wherein the compound is isopropyl 4-(((ethyl (methyl )amino)methylene)amino)-2, 5 -dimethylbenzoate hydrochloride ( S3a-HCl), having the following formulaS3a-HCI6D. A process comprising the steps of:(a) contacting the compound according to ID (S2 or salt thereof) with a mixture of a Lewis Acid and an acyl chloride in the presence of a solvent; and(b) contacting the resulting mixture of step (a) with i. water to provide S5 or an acceptable salt thereof, wherein Ri is H; or ii. an alcohol Ri-OH to provide S3 or an acceptable salt thereof, wherein Ri is Ci-Cs alkylS2 or salt thereof R-, = H, S5 or salt thereofR-, = C-pCs alkyl, S3 or salt thereof7D. The process according to 6D, wherein about 1 mole to about 5 moles of Lewis Acid per mole of S2 is used.8D. The process according to 7D, wherein about 1.5 moles to about 3.5 moles of Lewis Acid per mole of S2 is used.9D. The process according to any one of 6D-8D, wherein the Lewis Acid is boron trifluoride, iron trichloride, or aluminum trichloride.10D. The process according to 9D, wherein the Lewis Acid is aluminum trichloride.1 ID. The process according to any one of 6D-10D, wherein about 1 mole to about 5 moles of acyl chloride equivalent per mole of S2 is used.12D. The process according to 1 ID, wherein about 1.5 moles to about 3.5 moles of acyl chloride equivalent per mole of S2 is used.13D. The process according to any one of 6D-12D, wherein the acyl chloride is oxalyl dichloride, phosgene, diphosgene, triphosgene, methyl chloroformate, ethyl chloroformate or mixtures thereof.14D. The process according to 13D, wherein the acyl chloride is oxalyl dichloride.15D. The process according to any one of 6D-14D, wherein the solvent is chlorobenzene, di chlorobenzene, chloroform, dichloromethane, 1,2-dichloroethane, trichlorotoluene, toluene, or mixtures thereof.16D. The process according to 15D wherein the solvent is dichloromethane.17D. A process comprising: contacting S5 or acceptable salt thereof with S9 to produce SI or an acceptable salt, solvate, or hydrate thereof in the presence of a base, a solvent, and optionally a phase-transfer catalystS1or salt thereof18D. The process according to 17D, wherein about 1.0 mole to about 5 moles of base per mole of S5 is used.19D. The process according to 18D, wherein about 1.5 mole to about 3 moles of base per mole of S5 is used.20D. The process according to 17D, wherein about 2.0 moles to about 5 moles of base per mole of an acceptable salt of S5 is used.21D. The process according to 20D, wherein about 2.1 mole to about 4 moles of base per mole of an acceptable salt of S5 is used.22D. The process according to any one of 17D-21D, wherein the base is sodium methoxide, sodium ethoxide, A' .V-di isopropyl ethyl a ine, tri ethyl amine, potassium carbonate, cesium carbonate, sodium carbonate, sodium hydroxide, sodium bicarbonate, or mixtures thereof.23D. The process according to 22D, wherein the base is potassium carbonate.24D. The process according to any one of 17D-23D, wherein the solvent is water, ethyl acetate, acetone, acetonitrile, methyl ethyl ketone, A,A-dimethylformamide, dimethyl sulfoxide, isobutyl acetate, tetrahydrofuran, or mixtures thereof.25D. The process according to 24D, wherein the solvent is acetone, acetonitrile, ethyl acetate, water, or mixtures thereof.26D. The process according to any one of 17D-25D, wherein about 0.01 mole to about 0.5 mole of phase-transfer catalyst per mole of S5 or acceptable salt thereof is used.27D. The process according to 26D, wherein about 0.05 mole to about 0.15 mole of the phasetransfer catalyst per mole of S5 or acceptable salt thereof is used.28D. The process according to any one of 17D-27D, wherein the phase-transfer catalyst is tetramethylammonium bromide, tetraethylammonium bromide, tetrapropyl ammonium bromide, tetrabutylammonium bromide, benzyl triethylammonium chloride chloride, or mixtures thereof. 29D. The process according to 28D, wherein the phase-transfer catalyst is benzyltriethylammonium chloride.30D. A process comprising: contacting S3 or an acceptable salt thereof, wherein Ri is Ci-Cs alkyl, with S8 in the presence of a catalyst and a solvent to produce SI or an acceptable salt, solvate, or hydrate thereofS1 or salt thereof3 ID. The process according to 30D, wherein Ri is C1-C3 alkyl.32D. The process according to 30D or 3 ID, wherein the catalyst is a base catalyst.33D. The process according to any one of 30D-32D, wherein the catalyst is sodium methoxide (“NaOCJL”), potassium methoxide (“KOCH3”), sodium ethoxide (“NaOCHzCTh”), sodium pentoxide (“NaOCH2CH2CH2CH2CH3”), potassium Zc / 7-butoxide (“KO / -Bu”), potassium tert- amylate (“KO-t-Am”), sodium Zc / V-butoxide (“NaOt-Bu”), sodium hydroxide (“NaOH”), potassium hydroxide (“KOH”), sodium hydride (“NaH”), or mixtures thereof.34D. The process according to 33D, wherein the catalyst is sodium hydride or sodium methoxide.35D. The process according to any one of 30D-34D, wherein from about 1 mole to about 3 moles of base catalyst per mole of an acceptable salt of S3 is used.36D. The process according to 35D, wherein from about 1.0 mole to about 2.5 moles of base catalyst per mole of an acceptable salt of S3 is used.37D. The process according to any one of 30D-34D, wherein from about 0.01 mole to about 0.3 mole of base catalyst per mole of S3 is used.38D. The process according to 37D, wherein from about 0.05 mole to about 0.2 mole of base per mole of S3 is used.39D. The process according to 30D or 3 ID, wherein the catalyst is a Lewis acid catalyst.40D. The process according to any one of 30D, 3 ID, or 39D, wherein the catalyst is dibutyltin oxide, dibutyltin laurate, dibutyltin acetate, titanium isopropoxide, aluminum isopropoxide, zirconium isopropoxide, or mixtures thereof.41D. The process according to any one of 30D-3 ID or 39D-40D, wherein from about 0.05 mole to about 0.5 mole of Lewis acid catalyst per mole of S3 or an acceptable salt of S3 is used. 42D. The process according to 41D, wherein from about 0.1 mole to about 0.3 mole of Lewis acid catalyst per mole of S3 or an acceptable salt of S3 is used.43D. The process according to any one of 30D-42D, wherein the solvent is xylenes, mesitylene, 1,2-di chlorethane, trifluorotoluene, toluene, chlorobenzene, di chlorobenzene, benzonitrile, or mixtures thereof.44D. The process according to 43D, wherein the solvent is toluene or xylenes.45D. The process according to any one of 30D-44D, wherein the contacting is conducted at a temperature from about 25 °C to about 120 °C or from about 40 °C to 100 °C.46D. The process according to any one of 30D-45D, wherein the contacting is conducted at pressures from about 1 kilopascal (kPa) to about 200 kPa or from 1 kPa to about 101 kPa.47D. The process according to 17D or 30D, wherein SI or an acceptable salt, solvate or hydrate thereof is prepared as a solution.48D. A process to convert 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S1-HC1) or an acceptable solvate or hydrate thereof to 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable solvate or hydrate thereof in the presence of a base.49D. A process to convert SI or an acceptable solvate or hydrate thereof to S1-HC1 or an acceptable solvate or hydrate thereof in the presence of hydrogen chloride, wherein the hydrogen chloride is a gas or in solution, wherein the solution comprises an organic solvent or water.50D. A process to produce a crystalline form of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S1-HC1) or an acceptable solvate or hydrate thereof.5 ID. A process to produce a crystalline form of 4-(difluoromethoxy)benzyl 4-(((ethyl (methyl )amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable solvate or hydrate thereof.52D. A process comprising:(a) contacting S5 or an acceptable salt thereof, with a carboxylic acid activator in the presence of a solvent; and(b) contacting the reaction mixture of step (a) with i. S8 to provide SI or an acceptable salt, solvate, or hydrate thereof, or ii. an alcohol R3-OH to provide S3 or an acceptable salt thereof, wherein Ri is Ci-Cs alkylS3 or salt thereof53D. The process according to 52D, wherein the carboxylic acid activator is thionyl chloride, phosphorus pentachloride, or oxalyl dichloride.54D. The process according to 52D or 53D, wherein the solvent is toluene (“PhCHs”), ethyl acetate (“EtOAc”), dichloromethane (“DCM”), or tetrahydrofuran (“THF”).55D. The process according to any one of 52D-54D, wherein the process further comprising an optional base.56D. The process according to 55D, wherein the optional base is selected from the group consisting of triethylamine (“EtsN”), N, A-diisopropylethylamine (“DIPEA”), pyridine, sodium carbonate (“Na2CO3”), potassium carbonate (“K2CO3”), and sodium bicarbonate (“NaHCCh”). 57D. The process according to 56D, wherein the optional base is selected from the group consisting of sodium carbonate and potassium carbonate.58D. The process according to any one of 52D-57D, wherein the SI or acceptable salt, solvate, or hydrate thereof is isolated from the reaction mixture.59D. The process according to any one of 52D-57D, wherein the S3 or acceptable salt thereof is isolated from the reaction mixture.60D. The process according to 6D or 52D, wherein the resulting mixture of step (a) comprising an activated carboxylic acid S5-A or acceptable salt thereof, wherein A is ClS5-A or salt thereof
[0207] All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
[0208] The use of the terms “a” and “an” and “the” and “at least one” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The use of the term “at least one” followed by a list of one ormore items (for example, “at least one of A and B”) is to be construed to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
[0209] Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Claims
CLAIMSWhat is claimed is:
1. A compound, A’-(2,5-dimethylphenyl)-A-ethyl-A-methylformimidamide (S2), having the following formulaan acceptable salt thereof.
2. A compound (S3), wherein Ri is C3-C8 alkyl, having the following formula,S3 ,oran acceptable salt thereof.
3. A process comprising the steps of:(a) contacting the compound according to claim 1 with a mixture of a Lewis Acid and an acyl chloride in the presence of a solvent; and(b) contacting the resulting mixture of step (a) with i. water to provide S5 or an acceptable salt thereof, wherein Ri is H; or ii. an alcohol Ri-OH to provide S3 or an acceptable salt thereof, whereinRi is Ci-Cs alkylR-i = C-|-C8alkyl, S3 or salt thereof4. The process according to claim 3, wherein the Lewis Acid is boron trifluoride, iron trichloride, or aluminum trichloride.
5. The process according to claim 3 or claim 4, wherein the acyl chloride is oxalyl dichloride, phosgene, diphosgene, triphosgene, methyl chloroformate, ethyl chloroformate or mixtures thereof.
6. The process according to claim 5, wherein the acyl chloride is oxalyl dichloride.
7. The process according to any one of claims 3-5, wherein the solvent is chlorobenzene, dichlorobenzene, chloroform, dichloromethane, 1,2-dichloroethane, trichlorotoluene, toluene, or mixtures thereof.
8. The process according to claim 7 wherein the solvent is dichloromethane.
9. A process comprising the steps of:(a) contacting S5 or an acceptable salt thereof with an acyl chloride in the presence of a solvent; and(b) contacting the resulting mixture of step (a) with S8 to provide SI or an acceptable salt, solvate, or hydrate thereofS1or salt thereof10. The process according to claim 9, wherein the acyl chloride is oxalyl dichloride, phosgene, diphosgene, triphosgene, methyl chloroformate, ethyl chloroformate or mixtures thereof.
11. The process according to claim 10, wherein the acyl chloride is oxalyl di chloride.
12. The process according to any one of claims 9-11, wherein the solvent is toluene, ethyl acetate, dichloromethane, tetrahydrofuran, or mixtures thereof.
13. The process according to claim 3 or claim 9, wherein the resulting mixture of step (a) comprising an activated carboxylic acid S5-A or acceptable salt thereof, wherein A is ClS5-A or salt thereof14. A process to produce a crystalline form of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate hydrochloride (S1-HC1) or an acceptable solvate or hydrate thereof.
15. A process to produce a crystalline form of 4-(difluoromethoxy)benzyl 4- (((ethyl(methyl)amino)methylene)amino)-2,5-dimethylbenzoate (SI) or an acceptable solvate or hydrate thereof.